0001171843-17-003023.txt : 20170512 0001171843-17-003023.hdr.sgml : 20170512 20170512060043 ACCESSION NUMBER: 0001171843-17-003023 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20170511 FILED AS OF DATE: 20170512 DATE AS OF CHANGE: 20170512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: POET TECHNOLOGIES INC. CENTRAL INDEX KEY: 0001437424 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55135 FILM NUMBER: 17836272 BUSINESS ADDRESS: STREET 1: 121 RICHMOND STREET WEST STREET 2: SUITE 501 CITY: TORONTO, ONTARIO M5H 2K1 STATE: A6 ZIP: 00000 BUSINESS PHONE: 401-338-1212 MAIL ADDRESS: STREET 1: 121 RICHMOND STREET WEST STREET 2: SUITE 501 CITY: TORONTO, ONTARIO M5H 2K1 STATE: A6 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: OPEL INTERNATIONAL INC DATE OF NAME CHANGE: 20080611 6-K 1 f6k_051117.htm FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

_______________________________

 

FORM 6-K

 

_______________________________

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May, 2017

 

Commission File No. 000-55135

 

_______________________________

 

POET TECHNOLOGIES INC.

(Translation of registrant’s name into English)

 

_______________________________

 

121 Richmond Street West, Suite 501

Toronto, Ontario, M5H 2K1, Canada

(Address of principal executive offices)

 

_______________________________

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x         Form 40-F o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

 

 

 

 

 

 

EXHIBIT LIST

 

Exhibit No.   Description
     
99.1   Unaudited Consolidated Financial Statements for the Three Months Ended March 31, 2017
99.2   Management’s Discussion and Analysis for the Three Months Ended March 31, 2017
99.3   Certification of Interim Filings by Chief Executive Officer, dated May 11, 2017
99.4   Certification of Interim Filings by Chief Financial Officer, dated May 11, 2017

 

 

 

 

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: May 12, 2017 POET Technologies Inc.
   
  By: /s/ John Odonnell
  Name: John Odonnell
  Title: Secretary

 

 

 

 

EX-99.1 2 exh_991.htm EXHIBIT 99.1

Exhibit 99.1

 

 

 

 

 

 

 

 

 

NOTICE TO SHAREHOLDERS

For the Three Months Ended March 31, 2017

(Unaudited and Expressed in US Dollars)

 

POET TECHNOLOGIES INC.

 

 

 

 

 

 

 

Auditors' involvement

 

The auditors of POET Technologies Inc. have not performed a review of these condensed unaudited consolidated financial statements for the three months ended March 31, 2017 and March 31, 2016.

 

 

 

 

POET TECHNOLOGIES INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION      Audited 
(Expressed in US Dollars)  March 31,   December 31, 
   2017   2016 
Assets        
Current        
Cash  $11,082,183   $14,376,282 
Short -term investments (Note 2)   589,275    589,275 
Accounts receivable and unbilled revenue (Note 4)   417,708    292,849 
Prepaids and other current assets (Note 5)   742,736    758,917 
Inventory (Note 6)   1,057,209    1,116,880 
    13,889,111    17,134,203 
Property and equipment (Note 7)   8,970,018    9,364,210 
Patents and licenses (Note 8)   442,313    449,676 
Intangible assets (Note 9)   867,558    876,865 
Goodwill (Note 2)   7,681,003    7,681,003 
   $31,850,003   $35,505,957 
Liabilities          
           
Current          
Accounts payable and accrued liabilities (Note 10)  $548,812   $1,624,344 
    548,812    1,624,344 
           
Deferred tax liability   1,521,822    1,596,307 
Deferred rent   38,980    42,665 
    2,109,614    3,263,316 
           
Shareholders' Equity          
           
Share capital (Note 11(b))   103,357,862    103,357,862 
Warrants (Note 12)   5,985,378    5,985,378 
Contributed surplus (Note 13)   29,957,687    29,062,874 
Accumulated other comprehensive loss   (1,969,019)   (2,088,117)
Deficit   (107,591,519)   (104,075,356)
    29,740,389    32,242,641 
   $31,850,003   $35,505,957 

 

Commitments and contingencies (Note 15)

 

On behalf of the Board of Directors

 

/s/ Suresh Venkatesan  /s/ Chris Tsiofas
Director  Director

The accompanying notes are an integral part of these condensed consolidated financial statements.Page 2

 

POET TECHNOLOGIES INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND DEFICIT        
(Expressed in US Dollars)        
   Three Months Ended 
   March 31, 
   2017   2016 
Revenue  $712,550   $- 
           
Cost of sales   419,577    - 
Gross margin   292,973    - 
           
Operating expenses          
Selling, marketing and administration (Note 20)   2,953,461    2,249,483 
Research and development (Note 20)   949,967    669,819 
Impairment loss (Notes 2)   -    63,522 
Loss on disposal of property and equipment   -    16,931 
Other income, including interest   (19,807)   (20,802)
Operating expenses   3,883,621    2,978,953 
Net loss before income tax recovery   (3,590,648)   (2,978,953)
Income tax recovery   (74,485)   - 
Net loss   (3,516,163)   (2,978,953)
           
Deficit, beginning of period   (104,075,356)   (90,850,672)
Net loss   (3,516,163)   (2,978,953)
Deficit, end of period  $(107,591,519)  $(93,829,625)
Basic and diluted net loss per share (Note 14)  $(0.01)  $(0.01)

 

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS        
(Expressed in US Dollars)        
   Three Months Ended 
   March 31, 
   2017   2016 
         
Net loss  $(3,516,163)  $(2,978,953)
           
Other comprehensive income - net of income taxes          
Exchange differences on translating foreign operations   119,098    670,140 
Comprehensive loss  $(3,397,065)  $(2,308,813)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.Page 3

 

POET TECHNOLOGIES INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

(Expressed in US Dollars)

 

For the Three Months Ended March 31,  2017   2016 
Share Capital        
Beginning balance  $103,357,862   $81,027,171 
Funds from the exercise of warrants and compensation warrants   -    1,748,777 
Fair value of warrants and compensation warrants exercised   -    699,207 
Funds from the exercise of stock options   -    201,964 
Fair value assigned to stock options exercised   -    225,233 
March 31,   103,357,862    83,902,352 
Warrants          
Beginning balance   5,985,378    2,013,747 
Fair value of warrants and compensation warrants exercised   -    (699,207)
Fair value of expired warrants   -    (1,110,775)
March 31,   5,985,378    203,765 
Contributed Surplus          
Beginning balance   29,062,874    25,618,159 
Stock-based compensation   894,813    1,259,051 
Fair value of stock options exercised   -    (225,233)
Fair value of expired warrants   -    1,110,775 
March 31,   29,957,687    27,762,752 
Accumulated Other Comprehensive Loss          
Beginning balance   (2,088,117)   (2,388,987)
Other comprehensive income attributable to common shareholders - translation adjustment   119,098    670,140 
March 31,   (1,969,019)   (1,718,847)
Deficit          
Beginning balance   (104,075,356)   (90,850,672)
Net loss   (3,516,163)   (2,978,953)
March 31,   (107,591,519)   (93,829,625)
Total shareholders' equity  $29,740,389   $16,320,397 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.Page 4

 

POET TECHNOLOGIES INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Expressed in US Dollars)

For the Three Months Ended March 31,  2017   2016 
CASH (USED IN) PROVIDED BY:          
           
OPERATING ACTIVITIES          
           
Net loss  $(3,516,163)  $(2,978,953)
Adjustments for:          
Depreciation of property and equipment (Note 7)   518,535    76,914 
Amortization of patents and licenses (Note 8)   12,551    10,931 
Amortization of intangibles (Note 9)   9,307    - 
Loss on disposition of property and equipment   -    16,931 
Impairment of non-current asset held for sale   -    63,522 
Stock-based compensation (Note 13)   894,813    1,259,051 
Income tax recovery   (74,485)   - 
    (2,155,442)   (1,551,604)
Net change in non-cash working capital accounts:          
Accounts receivable and unbilled revenue   (112,482)   - 
Prepaid and other current assets   8,920    (490,383)
Inventory   99,555    - 
Accounts payable and accrued liabilities   (1,100,774)   (176,493)
Cash flows from operating activities   (3,230,223)   (2,218,480)
INVESTING ACTIVITIES          
           
Proceeds from the disposal of property and equipment   -    2,195 
Purchase of property and equipment (Note 7)   (124,343)   (85,210)
Purchase of patents and licenses (Note 8)   (5,188)   - 
Cash flows from investing activities   (129,531)   (83,015)
FINANCING ACTIVITIES          
           
Issue of common shares for cash, net of issue costs   -    1,950,741 
Cash flows from financing activities   -    1,950,741 
EFFECT OF EXCHANGE RATE CHANGES ON CASH   65,655    670,140 
NET CHANGE IN CASH   (3,294,099)   319,386 
CASH, beginning of period   14,376,282    14,409,996 
CASH, end of period  $11,082,183   $14,729,382 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.Page 5

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

1.DESCRIPTION OF BUSINESS

 

POET Technologies Inc. is incorporated in the Province of Ontario. POET Technologies Inc. and its subsidiaries (the "Company") are developers of the planar opto-electronic technology (“POET”) platform semiconductor process IP for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single die. The Company also designs, manufactures and sells photonic sensing and optical light source products. The Company's head office is located at 120 Eglinton Avenue East, Suite 1107, Toronto, Ontario, Canada M4P 1E2. These condensed unaudited consolidated financial statements of the Company were approved by the Board of Directors of the Company on May 11, 2017.

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

These condensed unaudited consolidated financial statements of the Company and its subsidiaries were prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board ("IASB").

 

These condensed unaudited interim consolidated financial statements do not include all of the information required for full annual financial statements and should be read in conjunction with the consolidated audited financial statements for the year ended December 31, 2016.

 

The preparation of financial statements in accordance with IAS 34 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed below:

 

Basis of presentation

These condensed unaudited consolidated financial statements include the accounts of POET Technologies Inc. and its subsidiaries; ODIS Inc. ("ODIS"), Opel Solar Inc., BB Photonics Inc., BB Photonics UK Limited (collectively "BB Photonics") and DenseLight Semiconductors Pte. Ltd ("DenseLight"). All intercompany balances and transactions have been eliminated on consolidation.

 

Business combinations

Acquisitions of businesses are accounted for using the acquisition method. The acquisition cost is measured at the acquisition date at the fair value of the consideration transferred, including all contingent consideration.

 

Subsequent changes in contingent consideration are accounted for through the condensed consolidated statements of operations and deficit and condensed consolidated statements of comprehensive loss in accordance with the applicable standards.

 

Goodwill arising on acquisition is initially measured at cost, being the difference between the fair value of the consideration transferred including the recognized amount of any non-controlling interest in the acquiree and the net recognized amount (generally fair value) of the identifiable assets and liabilities assumed at the acquisition date. If the net of the amounts of the identifiable assets acquired and liabilities assumed exceeds the sum of the consideration transferred, the amount of any non-controlling interests in the acquiree and the fair value of the acquirer’s previously held interest in the acquiree (if any), the excess is recognized immediately in profit or loss as a bargain purchase gain.

 

Acquisition-related costs, other than those that are associated with the issue of debt or equity securities that the Company incurs in connection with a business combination, are expensed as incurred.

 

Foreign currency translation

These condensed unaudited consolidated financial statements are presented in U.S. dollars ("USD"), which is the Company's presentation currency.

 

Page 6

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Items included in the financial statements of each of the Company's subsidiaries are measured using the currency of the primary economic environment in which the entity operates (the "functional currency"). Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities not denominated in the functional currency of an entity are recognized in the statement of operations and deficit.

 

Assets and liabilities of entities with functional currencies other than U.S. dollars are translated into the presentation currency at the year end rates of exchange, and the results of their operations are translated at average rates of exchange for the year. The resulting translation adjustments are included in accumulated other comprehensive loss in shareholders' equity. Additionally, foreign exchange gains and losses related to certain intercompany loans that are permanent in nature are included in accumulated other comprehensive loss.

 

Financial Instruments

Financial instruments are required to be classified as one of the following: held-to-maturity; loans and receivables, fair value through profit or loss; available-for-sale or other financial liabilities.

 

The Company's financial instruments include cash, short-term investments, accounts receivable, accounts payable and accrued liabilities. The Company designated its cash and short-term investments as fair value through profit or loss and its accounts payable and accrued liabilities as other financial liabilities.

 

Fair value through profit or loss financial assets are measured at fair value with gains and losses recognized in operations. Financial assets, loans and receivables and other financial liabilities are measured at amortized cost. Available-for-sale financial assets are measured at fair value with unrealized gains and losses recognized in other comprehensive loss.

 

Fair value of a financial instrument is the amount of consideration that would be agreed upon in an arm’s length transaction between knowledgeable, willing parties who are under no compulsion to act. The fair value of a financial instrument on initial recognition is the transaction price, which is the fair value of the consideration given or received. Subsequent to initial recognition, the fair value of a financial instrument that is quoted in active markets is based on the bid price for a financial asset held and the offer price for a financial liability. When an independent price is not available, fair value is determined by using a valuation methodology that refers to observable market data. Such a valuation technique includes comparisons with a similar financial instrument where an observable market price exists, discounted cash flow analysis, option pricing models and other valuation techniques commonly used by market participants. If no reliable estimate can be made, the Company measures the financial instrument at cost less impairment as a last resort.

 

Short-term investments

The short-term investments of $589,275 consist of guaranteed investment certificates (GICs) held with one Canadian chartered bank and earn interest at a rate of 0.50%. The GICs have maturity dates between May 2017 and October 2017. Investments are carried at fair value.

 

Page 7

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Accounts receivable

Accounts receivable are amounts due from customers from the sale of products or services in the ordinary course of business. Accounts receivables are classified as current (on the consolidated statements of financial position) if payment is due within one year of the reporting period date, and are initially recognized at fair value and subsequently measured at amortized cost.

 

The provision policy for doubtful accounts of the Company is based on the ageing analysis and management's ongoing evaluation of the recoverability of the outstanding receivables. A considerable amount of judgement is required in assessing the ultimate realization of these receivables, including the assessment of the creditworthiness and the past collection history of each customer. If the financial conditions of these customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. As at the balance sheet date, no provision was required for accounts receivable.

 

Inventory

Inventory consists of raw material inventory, work in process, and finished goods and are recorded at the lower of cost and net realizable value. Cost is determined on a first in first out basis and includes all costs of purchase, costs of conversion and other costs incurred in bringing the inventory to its present condition.

 

An assessment is made of the net realizable value of inventory at each reporting period. Net realizable value is the estimated selling price less the estimated cost of completion and the estimated costs necessary to make the sale. When circumstances that previously caused inventories to be written down no longer exist or when there is clear evidence of an increase in net realizable value because of changed economic circumstances, the amount of any write down previously recorded is reversed so that the new carrying amount is the lower of the cost and the revised net realizable value. Raw materials are not written down unless the goods in which they are incorporated are expected to be sold for less than cost, in which case, they are written down by reference to replacement cost of the raw materials, as this is the best indicator of net realizable value.

 

Property and equipment

Property and equipment are recorded at cost. Depreciation is calculated based on the estimated useful life of the asset using the following method and useful lives:

 

Machinery and equipment  Straight Line, 5 years
Leasehold improvements  Straight Line, 5 years or life of the lease, whichever is less
Office equipment  Straight Line, 5 years

 

Patents and licenses

Patents and licenses are recorded at cost and amortized on a straight line basis over 12 years. Ongoing maintenance costs are expensed as incurred.

 

Impairment of long-lived assets

The Company’s tangible and intangible assets are reviewed for indications of impairment whenever events or changes in circumstances indicate that the carrying amounts of the assets may not be recoverable. An assessment is made at each reporting date whether there is any indication that an asset may be impaired.

 

Page 8

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

An impairment loss is recognized when the carrying amount of an asset exceeds its recoverable amount. Impairment losses are recognized in profit and loss for the year. The recoverable amount is the greater of the asset’s fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit ("CGU") to which the asset belongs.

 

An impairment loss is reversed if there is an indication that there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

 

The Company reported an impairment loss of $63,522 for the three months ended March 31, 2016 and year ended December 31, 2016. No impairment loss has been recorded for the three months ended March 31, 2017.

 

Goodwill

Goodwill represents the excess of the cost of an acquired business over the fair value of the identifiable assets acquired net of liabilities assumed. Goodwill is measured at cost less accumulated impairment losses and is not amortized. Goodwill is tested for impairment on an annual basis or whenever facts or circumstances indicate that the carrying amount may exceed its recoverable amount. Goodwill amounting to $7,681,003 arose in connection with the acquisition of DenseLight on May 11, 2016 and BB Photonics, Inc. on June 22, 2016.

 

Income taxes

The Company follows the liability method of accounting for income taxes. Under this method, deferred income taxes are provided on differences between the financial reporting and income tax bases of assets and liabilities and on income tax losses available to be carried forward to future years for tax purposes. Deferred income taxes are measured using the substantively enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. Valuation allowances are provided to reduce deferred income tax assets to the amount expected to be realized.

 

Revenue recognition

Sale of goods

Revenue from the sale of goods is recognized when significant risks and rewards of ownership are transferred to the buyer, there is persuasive evidence of an arrangement, collection is probable and fees are fixed and determinable.

 

Service revenue

Revenue from services that are one year or less is recognized when the services are completed. Revenue from services of a long-term nature is recognized by reference to the stage of completion of the transaction at the end of the reporting period determined by services performed to date as a percentage of total services and the amount of revenue, stage of completion, and the costs incurred for the transaction and the costs to complete the transaction can be measured reliably.

 

Interest income

Interest income on cash or short-term investments classified as fair value through profit or loss is recognized as earned using the effective interest method.

 

Page 9

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Intangible assets

Research and development costs

Research costs are expensed in the year incurred. Development costs are also expensed in the year incurred unless the Company believes a development project meets IFRS criteria as set out in IAS 38, Intangible Assets, for deferral and amortization. IAS 38 requires all research costs be charged to expense while development costs are capitalised only after technical and commercial feasibility of the asset for sale or use have been established. This means that the entity must intend and be able to complete the intangible asset and either use it or sell it and be able to demonstrate how the asset will generate future economic benefits. Development costs are tested for impairment whenever events or changes indicate that its carrying amount may not be recoverable.

 

In-Process Research and Development

Under IFRS, in-process research and development ("IPR&D") acquired in a business combination that meets the definition of an intangible asset is capitalized with amortization commencing when the asset is ready for use (i.e., when development is complete). The Company acquired $714,000 of IPR&D when it acquired BB Photonics Inc.

 

Customer relationships

Intangible assets include customer relationships. Customer relationships is an externally acquired intangible asset and is measured at cost less accumulated amortization and any accumulated impairment losses. Customer relationships are amortized on a straight-line basis over their estimated useful lives and is tested for impairment whenever events or changes indicate that their carrying amount may not be recoverable. Customer relationships of $186,131 was acquired when the the Company acquired DenseLight. The useful life of customer relationships was determined to be 5 years.

 

Stock-based compensation

Stock options and warrants awarded to non employees are accounted for using the fair value of the instrument awarded or service provided whichever is considered more reliable. Stock options and warrants awarded to employees are accounted for using the fair value method. The fair value of such stock options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.

 

Loss per share

Basic loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period after giving effect to potentially dilutive financial instruments. The dilutive effect of stock options and warrants is determined using the treasury stock method.

 

Page 10

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

3.RECENT ACCOUNTING PRONOUNCEMENTS

 

The following is a summary of recent accounting pronouncements that may affect the Company:

 

IFRS 15, Revenue from Contracts with Customers ("IFRS 15"). The IASB issued IFRS 15, which is effective for annual periods beginning on or after January 1, 2017. The standard contains a single model that applies to contracts with customers and two approaches to recognizing revenue: at a point in time and over time. The model features a contract-based five-step analysis of transactions to determine whether, how much and when revenue is recognized. New estimates and judgmental thresholds have been introduced, which may affect the amount and/or timing of revenue recognized. The Company is in the process of assessing the impact of this standard on its consolidated financial statements.

 

IFRS 16, Leases (“IFRS 16”) sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, the customer (lessee) and the supplier (lessor). This will replace IAS 17, Leases (“IAS 17”) and related Interpretations. IFRS 16 provides revised guidance on identifying a lease and for separating lease and non-lease components of a contract. IFRS 16 introduces a single accounting model for all lessees and requires a lessee to recognize right-of-use assets and lease liabilities for leases with terms of more than 12 months, unless the underlying asset is of low value, and depreciation of lease assets is reported separately from interest on lease liabilities in the income statement. Under IFRS 16, lessor accounting for operating and finance leases will remain substantially unchanged. IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with earlier application permitted for entities that apply IFRS 15, Revenue from Contracts with Customers. The Company is in the process of assessing the impact of this standard on its consolidated financial statements.

 

4.ACCOUNTS RECEIVABLE

 

The carrying amounts of accounts receivable approximate their fair value and are originally denominated in the following currencies before conversion to US dollars below:

 

      March 31,   December 31, 
      2017   2016 
            
Product sales  United States dollar  $417,708   $292,849 
      $417,708   $292,849 

 

In determining the recoverability of a trade receivable, the Company considers any change in the credit quality of the trade receivable from the date credit was initially granted up to the reporting date. The trade receivables that are neither past due nor impaired relates to customers that the company has assessed to be creditworthy based on the credit evaluation process performed by management.

 

5.PREPAIDS AND OTHER CURRENT ASSETS

 

The following table reflects the details of prepaids and other current assets:

 

   March 31,   December 31, 
   2017   2016 
         
Sales tax recoverable and other current assets  $188,473   $147,119 
Security deposits on leased properties   270,350    272,026 
Equipment and materials deposit   283,913    339,772 
   $742,736   $758,917 

 

Page 11

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

6.INVENTORY

 

   March 31,   December 31, 
   2017   2016 
Raw materials  $361,848   $662,458 
Finished goods   422,187    358,386 
Work in process   273,174    96,036 
   $1,057,209   $1,116,880 

 

7.PROPERTY AND EQUIPMENT

 

   Equipment not   Leasehold   Machinery and   Office     
   in service   improvements   equipment   equipment   Total 
Cost                    
Balance, January 1, 2016  $-   $16,072   $1,400,103   $81,691   $1,497,866 
Additions   602,830    667,342    8,498,051    244,860    10,013,083 
Disposals   -    (16,072)   (64,747)   (11,734)   (92,553)
Reclassification   -    -    (98,522)   -    (98,522)
Balance, December 31, 2016   602,830    667,342    9,734,885    314,817    11,319,874 
Additions   -    -    111,743    12,600    124,343 
Reclassification/impairment   (263,780)   -    263,780    -    - 
Balance,March 31, 2017   339,050    667,342    10,110,408    327,417    11,444,217 
                          
Accumulated Depreciation                         
Balance, January 1, 2016   -    3,104    523,198    24,457    550,759 
Depreciation for the year   -    83,189    1,320,050    45,286    1,448,525 
Disposals   -    (3,104)   (34,940)   (5,576)   (43,620)
Balance, December 31, 2016   -    83,189    1,808,308    64,167    1,955,664 
Depreciation for the period   -    47,331    457,285    13,919    518,535 
Balance, March 31, 2017   -    130,520    2,265,593    78,086    2,474,199 
                          
Carrying Amounts                         
At December 31, 2016  $602,830   $584,153   $7,926,577   $250,650   $9,364,210 
At March 31, 2017  $339,050   $536,822   $7,844,815   $249,331   $8,970,018 

 

8.PATENTS AND LICENSES

 

     
Cost    
Balance, January 1, 2016  $537,249 
Additions   72,638 
Balance, December 31, 2016   609,887 
Additions   5,188 
Balance, March 31, 2017   615,075 
      
Accumulated Depreciation     
Balance, January 1, 2016   110,436 
Amortization   49,775 
Balance, December 31, 2016   160,211 
Amortization   12,551 
Balance, March 31, 2017   172,762 

 

Page 12

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

8.PATENTS AND LICENSES (Continued)

 

Carrying Amounts    
At December 31, 2016  $449,676 
At March 31, 2017  $442,313 

 

9.INTANGIBLE ASSETS

 

       Customer     
   Technology   Relationships   Total 
Cost            
Balance, January 1, 2016  $-   $-   $- 
Acquired through the acquisition of DenseLight   -    186,131    186,131 
Acquired through the acquisition of BB Photonics   714,000    -    714,000 
Balance, December 31, 2016 and March 31, 2017   714,000    186,131    900,131 
                
Accumulated Depreciation               
Balance, January 1, 2016   -    -    - 
Depreciation for the year   -    23,266    23,266 
Balance, December 31, 2016   -    23,266    23,266 
Depreciation for the period   -    9,307    9,307 
Balance, March 31, 2017   -    32,573    32,573 
                
Carrying Amounts               
At December 31, 2016  $714,000   $162,865   $876,865 
At March 31, 2017  $714,000   $153,558   $867,558 

 

10.ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

   March 31,   December 31, 
   2017   2016 
         
Trade payable  $386,347   $768,066 
Payroll related liabilities   45,473    628,378 
Accrued liabilities   81,207    183,037 
Lease commitment   35,785    44,863 
   $548,812   $1,624,344 

 

Page 13

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

11.SHARE CAPITAL

 

(a)      AUTHORIZED

Unlimited number of common shares

One special voting share

 

(b)      COMMON SHARES ISSUED

 

   Number of     
   Shares   Amount 
January 1, 2016   197,097,815    81,027,171 
Shares issued on public offering   34,800,000    9,349,254 
Cost of shares issued on public offering   -    (1,165,017)
Fair value of warrants issued   -    (5,985,378)
Shares issued to settle subsidiary accounts payable   2,386,386    1,843,629 
Shares issued on business combination   15,607,240    12,050,000 
Shares issued on the exercise of stock options   5,648,000    1,654,988 
Fair value of stock options exercised   -    1,737,879 
Shares issued on the exercise of warrants and compensation warrants   3,794,412    1,943,919 
Fair value of warrants exercised   -    901,417 
Balance, December 31, 2016 and March 31, 2017   259,333,853   $103,357,862 

 

12.WARRANTS

 

The following table reflects the continuity of warrants:

 

   Average Exercise   Number of   Historical 
   Price   Warrants   Fair value 
Balance, January 1, 2016   0.79    8,369,233    2,013,747 
Warrants issued   0.39    34,800,000    5,985,378 
Warrants and compensation warrants exercised   (0.51)   (3,794,412)   (901,417)
Expired   (1.02)   (4,574,821)   (1,112,330)
Balance, December 31, 2016 and March 31, 2017  $0.39    34,800,000   $5,985,378 

 

13.STOCK OPTIONS AND CONTRIBUTED SURPLUS

 

Stock Options

On July 7, 2016, shareholders of the Company approved amendments to the Company's fixed 20% stock option plan (as amended, referred to as the "2016 Plan"). Under the 2016 Plan, the board of directors may grant options to acquire common shares of the Company to qualified directors, officers, employees and consultants. The 2016 Plan provides that the number of common shares issuable pursuant to options granted under the 2016 Plan and pursuant to other previously granted options is limited to 44,352,885 (the “Number Reserved”). Any subsequent increase in the Number Reserved must be approved by shareholders of the Company and cannot, at the time of the increase, exceed 20% of the number of issued and outstanding shares. The stock options vest in accordance with the policies determined by the Board of Directors from time to time consistent with the provisions of the 2016 Plan which grants discretion to the Board of Directors.

 

Page 14

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

13.STOCK OPTIONS AND CONTRIBUTED SURPLUS (Continued)

 

Stock option transactions and the number of stock options outstanding were as follows:

 

   Weighted average     
   Number of   Exercise 
   Options   Price 
Balance, January 1, 2016   26,718,500   $0.89 
Expired/cancelled   (1,290,000)   0.96 
Exercised   (5,648,000)   0.37 
Granted   4,025,000    0.62 
Balance, December 31, 2016   23,805,500    0.96 
Expired/cancelled   (250,000)   0.66 
Granted   4,125,000    0.28 
Balance, March 31, 2017   27,680,500   $0.86 

 

During the period ended March 31, 2017, the Company granted 4,125,000 (Q1 2016 - 300,000) stock options to officers, employees and consultants of the Company to purchase common shares at an average price of $0.28 (Q1 2016 - $0.74) per share.

 

During the period ended March 31, 2017, the Company recorded stock-based compensation of $894,813 (Q1 2016 - $1,259,051) relating to stock options that vested during the period.

 

The stock options granted were valued using the Black-Scholes option pricing model using the following assumptions:

 

   2017   Q1 2016 
         
Weighted average exercise price  $0.28   $0.74 
Weighted average risk-free interest rate   1.73%   1.29%
Weighted average dividend yield   0%   0%
Weighted average volatility   103.48%   105.7%
Weighted average estimated life   10 years    10 years 
Weighted average share price  $0.28   $0.74 

 

Share price on the various grant dates were:

 

First grant  $0.32   $0.75 
Second grant   0.27    0.74 
Third grant   0.25    - 
Fourth grant   0.28    - 

 

The underlying expected volatility was determined by reference to the Company's historical share price movements, its dividend policy and dividend yield and past experience relating to the expected life of granted stock options.

 

Page 15

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

13.STOCK OPTIONS AND CONTRIBUTED SURPLUS (Continued)

 

The weighted average remaining contractual life and weighted average exercise price of options outstanding and of options exercisable as at March 31, 2017 are as follows:

 

Options Outstanding    Options Exercisable 
   Weighted                 
   Weighted   Average   Weighted         
   Average   Remaining   Average         
Exercise  Number   Exercise   Contractual   Number   Exercise 
Range  Outstanding   Price   Life (years)   Exercisable   Price 
$0.11 - $0.25   860,000   $0.23    1.66    860,000   $0.23 
$0.28 - $0.31   487,500   $0.28    0.46    487,500   $0.28 
$0.34 - $0.37   550,000   $0.34    9.23    50,000   $0.33 
$0.38 - $0.86   10,531,000   $0.40    6.79    3,538,813   $0.45 
$0.87 - $1.64   15,252,000   $1.24    3.10    8,188,624   $1.26 
    27,680,500   $0.86    3.10    13,124,937   $0.93 

 

Contributed Surplus

 

The following table reflects the continuity of contributed surplus:

 

   Amount 
Balance, January 1, 2016  $25,618,159 
Stock-based compensation   4,070,264 
Fair value of stock options exercised   (1,737,879)
Fair value of expired warrants   1,112,330 
Balance, December 31, 2016   29,062,874 
Stock-based compensation   894,813 
Balance, March 31, 2017  $29,957,687 

 

14.LOSS PER SHARE

 

   Three Months Ended 
   March 31, 
   2017   2016 
Numerator        
Net loss  $(3,516,163)  $(2,978,953)
Denominator          
Weighted average number of          
common shares outstanding   259,333,853    199,133,270 
Weighted average number of common          
shares outstanding - diluted   259,333,853    199,133,270 
Basic and diluted loss per share  $(0.01)  $(0.01)

 

The effect of common share purchase options, warrants, compensation warrants and shares to be issued on the net loss in 2017 and 2016 is not reflected as they are anti-dilutive.

 

Page 16

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

15.COMMITMENTS AND CONTINGENCIES

 

The Company has three facilities; head office located in Toronto, Canada, development operations located in San Jose, California and operating facilities located in Singapore. The Company has operating leases for development operations and operating facilities. The Company's development operations terminated a lease on January 31, 2017 and initiated a new lease an February 1, 2017 which expires on January 31, 2020. The lease on the Company's operating facilities expires on February 15, 2019. As at March 31, 2017, the Company's head office was on a month to month lease term.

 

Rent expense under these leases was $106,353 for the three months ended March 31, 2017 (Q1 2016 - $67,063).

 

Remaining minimum annual rental payments to the lease expiration date is as follows:

 

April 1, 2017 to March 31, 2018  $401,912 
April 1, 2018 through 2020   380,746 
   $782,658 

 

16.RELATED PARTY TRANSACTIONS

 

Compensation to key management personnel were as follows:

 

   Three Months Ended 
   March 31, 
   2017   2016 
         
Salaries  $268,633   $554,290 
Share-based payments (1)   723,453    908,463 
Total  $992,086   $1,462,753 

 

(1) Share-based payments are the fair value of options granted to key management personnel and expensed during the various periods as calculated using the Black-Scholes model.

 

The Company paid or accrued $28,313 in fees for the three months ended March 31, 2017 (Q1 2016 - $27,337) to a law firm, of which a director is counsel, for legal services rendered to the Company. During the period ended March 31, 2017, the Company paid the final installment of $25,000 on a total of $150,000 of consulting fees to a director which were charged against the financing concluded on November 2, 2016.

 

All transactions with related parties have occurred in the normal course of operations and are measured at the exchange amounts, which are the amounts of consideration established and agreed to by the related parties.

 

Page 17

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

17.SEGMENT INFORMATION

 

The Company and its subsidiaries operate in a single segment; the design, manufacture and sale of semi-conductor products and services for commercial applications. The Company’s operating and reporting segment reflects the management reporting structure of the organization and the manner in which the chief operating decision maker regularly assesses information for decision making purposes, including the allocation of resources. A summary of the Company's operations is below:

 

ODIS

Odis is the developer of the POET platform semiconductor process IP for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single die.

 

BB Photonics

BB Photonics develops photonic integrated components for the datacenter market utilizing embedded dielectric technology that is intended to enable onchip athermal wavelength control and lower the total solution cost of datacenter photonic integrated circuits.

 

DenseLight

DenseLight designs, manufactures, and delivers photonic optical light source products and solutions to the communications, medical, instrumentations, industrial, defense, and security industries. DenseLight processes III-V based optoelectronic devices and photonic integrated circuits through its in-house wafer fabrication and assembly & test facilities.

 

On a consolidated basis, the Company operates geographically in Singapore, the United States and Canada. Geographical information is as follows:

 

   2017 
As of March 31,   Singapore    US    Canada    Consolidated 
Current assets  $2,308,960   $8,547,731   $3,032,420   $13,889,111 
Property and equipment   8,600,712    367,006    2,300    8,970,018 
Patents and licenses   -    442,313    -    442,313 
Goodwill and intangibles assets   7,076,842    1,471,719    -    8,548,561 
Total Assets  $17,986,514   $10,828,769   $3,034,720   $31,850,003 

 

                 
Three Months Ended March 31,  Singapore   US   Canada   Consolidated 
Sales  $(712,550)  $-   $-   $(712,550)
Cost of sales   419,577    -    -    419,577 
Selling, marketing and                    
administration   1,225,509    1,514,784    213,168    2,953,461 
Research and development   291,105    608,052    50,810    949,967 
Impairment loss   -    -    -    - 
Loss on disposal of property                    
and equipment   -    -    -    - 
Other income including                    
Investment income   (11,742)   -    (8,065)   (19,807)
Net loss from operations  $1,211,899   $2,122,836   $255,913   $3,590,648 

 

Page 18

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

17.SEGMENT INFORMATION (Continued)

 

   2016 
As of December 31,  Singapore   US   Canada   Consolidated 
Current assets  $2,118,561   $10,058,018   $4,957,624   $17,134,203 
Property and equipment   9,039,069    322,633    2,508    9,364,210 
Patents and licenses   -    449,676    -    449,676 
Goodwill and intangible assets   7,086,149    1,471,719    -    8,557,868 
Total Assets  $18,243,779   $12,302,046   $4,960,132   $35,505,957 

 

                 
For the three months ended March 31,  Singapore   US   Canada   Consolidated 
General and administration  $-   $1,843,363   $406,120   $2,249,483 
Research and development   -    669,819    -    669,819 
Impairment loss   -    63,522    -    63,522 
Loss on disposal of property and                    
equipment   -    -    16,931    16,931 
Other income   -    -    (20,802)   (20,802)
Net loss from operations  $-   $2,576,704   $402,249   $2,978,953 

 

18.FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

 

The Company's financial instruments consist of cash, short-term investments, accounts receivable, and accounts payable and accrued liabilities. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest risk arising from these financial instruments. The Company estimates that the fair value of these instruments approximates fair value due to their short term nature.

 

The Company has classified financial assets and (liabilities) as follows:

 

   March 31,   December 31, 
   2017   2016 
         
Fair value through profit or loss, measured at fair value:          
Cash  $11,082,183   $14,376,282 
Short-term investments   589,275    589,275 
Loans and receivable, measured at amortized cost:          
Accounts receivable   417,708    292,849 
Other liabilities, measured at amortized cost:          
Accounts payable and accrued liabilities   (548,812)   (1,624,344)

 

Financial instruments recorded at fair value on the balance sheet are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels:

 

Level 1 - valuation based on quoted prices (unadjusted) observed in active markets for identical assets or liabilities.

Level 2 - valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly.

Level 3 - valuation techniques based on inputs for the asset or liability that are not based on observable market data.

 

Cash was determined using level 1 inputs. Short-term investments were determined using level 2 inputs.

 

Page 19

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

18.FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Continued)

 

Credit Risk

The Company is exposed to credit risk associated with its accounts receivable. The Company has accounts receivable from both governmental and non-governmental agencies. Credit risk is minimized substantially by ensuring the credit worthiness of the entities with which it carries on business. Credit terms are provided on a case by case basis. The Company has not experienced any significant instances of non-payment from its customers.

 

The Company's accounts receivable ageing was as follows:

 

   March 31,   December 31, 
   2017   2016 
         
Current  $103,793   $125,610 
31 - 60 days   244,837    16,346 
61 - 90 days   17,010    75,816 
> 90 days   52,068    75,077 
   $417,708   $292,849 

 

Exchange Rate Risk

The functional currency of each of the entities included in the accompanying consolidated financial statements is the local currency where the entity is domiciled. Functional currencies include the US, Singapore and Canadian dollar. Most transactions within the entities are conducted in functional currencies. As such, none of the entities included in the consolidated financial statements engage in hedging activities. The Company is exposed to a foreign currency risk with the Canadian and Singapore dollar. A 10% change in the Canadian and Singapore dollar would increase or decrease other comprehensive loss by $490,235.

 

Liquidity Risk

The Company currently does not maintain credit facilities. The Company's existing cash and cash resources are considered sufficient to fund operating and investing activities beyond one year from the issuance of these unaudited condensed consolidated financial statements.

 

19.       CAPITAL MANAGEMENT

 

In the management of capital, the Company includes shareholders' equity (excluding accumulated other comprehensive loss and deficit), cash and short-term investments. The components of capital on March 31, 2017 were:

 

Cash and short-term investments  $11,671,458 
Shareholders' equity  $139,300,927 

 

The Company's objective in managing capital is to ensure that financial flexibility is present, a) to increase shareholder value through growth; b) to respond to changes in economic and/or market conditions; c) to maintain a strong capital base so as to retain investor, creditor and market confidence; d) to sustain future development of the business; and e) to safeguard the Company's ability to obtain financing should the need arise.

 

In maintaining its capital, the Company has a strict investment policy which includes investing its surplus capital only in highly liquid, highly rated financial instruments.

 

The Company reviews its capital management approach on an ongoing basis.

 

Page 20

 

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

 

20.EXPENSES

 

Research and development costs can be analysed as follows:

 

   Three Months Ended 
   March 31, 
   2017   2016 
Subcontract fees  $405,290   $220,528 
Wages and benefits   266,326    259,202 
Supplies   186,934    50,739 
Stock-based compensation   91,417    139,350 
   $949,967   $669,819 

 

Selling, marketing and administration costs can be analysed as follows:

 

Wages and benefits  $934,333   $483,169 
Stock-based compensation   803,396    1,119,701 
Depreciation and amortization   540,393    87,844 
General expenses   308,850    185,069 
Professional fees   155,742    140,200 
Rent   106,816    75,695 
Management and consulting fees   103,931    157,805 
   $2,953,461   $2,249,483 

 

 

 

 

 

 

 

 

Page 21

 

EX-99.2 3 exh_992.htm EXHIBIT 99.2

 

Exhibit 99.2

 

 

 

 

 

 

POET

TECHNOLOGIES INC.

 

 

Management’s Discussion

and Analysis

For the Three Months Ended March 31, 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

POET Technologies Inc.

Suite 1107 – 120 Eglinton Avenue East

Toronto, Ontario, Canada M4P 1E2

Tel: (416) 368-9411 Fax: (416) 322-5075

 

 

 

Management’s Discussion and Analysis

For Three Months Ended March 31, 2017

 

The following discussion and analysis of the operations, results, and financial position of POET Technologies Inc., (the “Company”) for the three months ended March 31, 2017 (the “Period”) should be read in conjunction with the Company’s condensed unaudited interim consolidated financial statements for the three months ended March 31, 2017 and the Company’s audited consolidated financial statements for the year ended December 31, 2016 and the related notes thereto both of which were prepared in accordance with International Financial Reporting Standards (“IFRS”). The effective date of this report is May 11, 2017. All financial figures are in United States dollars (“USD”) unless otherwise indicated. The abbreviation “U.S.” used throughout refers to the United States of America.

 

Forward-Looking Statements

 

This management discussion and analysis contains forward-looking statements that involve risks and uncertainties. It uses words such as “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, and other similar expressions to identify forward-looking statements. Forward-looking statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ from those reflected in the forward-looking statements, including, without limitation, risks and uncertainties relating to the early stage of the Company’s development and the possibility that future development of the Company’s technology and business will not be consistent with management’s expectations, difficulties in achieving commercial production or interruptions in such production if achieved, inherent risks of operating a manufacturing facility, including risks associated with supplier delays, factory uptime, inventory management and other operating uncertainties, the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, the uncertainty of profitability and failure to obtain adequate financing on a timely basis. The Company undertakes no obligation to update forward-looking statements if circumstances or Management’s estimates or opinions should change, except to the extent required by law. The reader is cautioned not to place undue reliance on forward-looking statements.

 

The Company is incorporated under the laws of the Province of Ontario. The Company’s shares trade under the symbol “PTK” on the TSX Venture Exchange in Canada and under the symbol “POETF” on the OTCQX in the U.S.

 

BUSINESS

 

Overview

 

We are an advanced semiconductor development and manufacturing company dedicated to enabling the integration of photonics and electronics through both monolithic and hybrid approaches to device design and packaging. The favorable economics of integration have been well established in silicon-based electronics, as demonstrated by Very Large Scale Integrated (VLSI) circuits. Through integration, we believe that the Company can capture a meaningful portion of the market for photonics devices that address the need for increased bandwidth, speed and sensitivity across a range of high growth data communications and photonic sensing applications. We believe that the integration of discrete functions onto fewer devices or ultimately onto a single chip is the optimal way to lower cost, reduce size, limit power consumption and increase the performance, scalability and value of photonics devices, making opto-electronics a more viable economic proposition.

 

 1 
 

 

The cost of building silicon-based devices today contrasts sharply with the cost of building photonics-based devices. While the majority of the cost of building silicon-based devices is in fabricating the device on the wafer, the majority of the cost of building photonics devices today is in the packaging and testing process. It is inevitable that these costs will be reduced through integration. By deploying novel approaches to both monolithic and hybrid integration of photonics devices, we believe the Company can become a global leader in photonics.

 

Over the past few years, our Company has been focused on monolithic integration, based on our proprietary POET gallium arsenide-based (GaAs) platform. POET has developed a design for a single, monolithic semiconductor chip (our “photonic engine” technology) that has all of the elements needed to communicate data at the speed of light, yet with the lower cost profile of copper. We believe we are the only company that has demonstrated the capability to cost effectively integrate multiple electronic and optical functions on a single chip. The POET photonic engine, as designed, integrates at least three essential discrete devices onto a single GaAs chip: a vertical-cavity surface-emitting laser (VCSEL), a photodetector and an electronic circuit based on either a thyristor or a heterostructure field-effect transistor (HFET).

 

A single chip solution is not only the lowest cost approach to photonic integration, it has the added benefits of lower power consumption and smaller size – all by a factor of 2X to 10X compared to conventional solutions. The added benefits of lower power and smaller size could open up entirely new markets for photonic applications, including in mobile devices and ultimately on-board chip-to-chip data transfer (“inside the box”). By integrating multiple device functions, we believe we can capture the combined value associated with discrete devices, such as lasers, detectors and multiplexers, disrupting the market for conventional solutions and creating new and expanded applications for our photonic engine technology.

 

We expect that the first application of the POET photonic engine technology will be in the data center market, initially in the form of Active Optical Cables (AOCs), a market that is today largely served by Direct Attach Copper (DAC) cables. This “ultra short reach” segment of the data communications market covers distances of less than five meters at datacom speeds of 25 to 100 Gigabits per second (Gbs). By providing a monolithically integrated solution, we believe we can disrupt the market for copper-based short reach datacom, with a simple, low cost, scalable device that consumes vastly lower power. According to LightCounting, the current market size for GaAs-based AOCs is $339 million, growing to $779 million by 2021. The expected growth is the result of major cloud-based data center operators committing to AOCs because of the higher cost associated with the power consumption of copper-based cables. “The application of GaAs VCSEL technology in Active Optical Cables (AOCs) and Embedded Optical Modules (EOMs) is the fastest growing market opportunity. Low cost and power consumption of VCSELs make AOCs and EOMs products competitive with copper connectivity.”1

 

In addition to monolithic integration, we are developing solutions based on a novel “hybrid” integration approach, which combines Indium Phosphide (InP)-based photonics chips and dielectric waveguide devices on a silicon base into a single package. This approach enables the replacement of high-cost optical components, such as mirrors and lenses, with embedded dielectric devices, dramatically lowering the cost of potential solutions aimed at the “medium-reach” segment of the data communications market (i.e., 500m–10 kilometers). Our ability to address hybrid integration is a direct result of our acquisitions, in 2016, of DenseLight Semiconductor Pte. Ltd. (“DenseLight”) based in Singapore, and BB Photonics, Inc. based in New Jersey.

 

   

 

1 LightCounting Integrated Optical Devices, January 2016

 

 2 
 

 

Historically, DenseLight has manufactured and sold a range of InP-based devices, primarily superluminescent light emitting diodes (SLEDs) for use in optical networks and sensing platforms. These devices span a variety of form factors, including chips, modules and high-value, programmable subsystems. Recently, we announced the expected availability in 2017 of narrow linewidth lasers for test and measurement applications, including LIDAR, as well as a newly designed de-multiplexer chip, based on a proprietary design from BB Photonics. POET is applying the intellectual property acquired from BB Photonics to its DenseLight product portfolio in several novel ways to lower overall module cost by eliminating the conventional gold box hermetic packaging, which is a complex process that requires active alignment and the use of lenses and metallized fibers. By incorporating BB Photonics designs for waveguide multiplexers and filters, we believe the packaging costs of our DenseLight modules can be reduced by up to 70% from current levels. This combination of DenseLight and BB Photonics under the POET umbrella offers an unprecedented opportunity for the Company to address the market for sensing products with novel low-cost solutions. In addition, we believe it will allow POET to pursue the large and growing market for 100G and potentially 400G transceiver products, with both integrated transceivers as well as active and passive components.

 

InP-based transceivers currently represent a $4.5 billion market, according to LightCounting, growing to over $7 billion, largely as a result of the proliferation of hybrid integration aimed at reducing the cost of the optical components.2 The majority of today’s disaggregated suppliers shipping 100G transceivers in a 4x25G format have developed assembly methods for placing multiple laser chips on one substrate and coupling the output into one fiber using micro-optic filters and other elements. POET’s approach is to develop Dielectric-InP Photonics, by combining athermal dielectric waveguides, integrated lasers, PIN diodes and discrete electronics. This example of “hybrid” integration involves the placement of both monolithically integrated and discrete devices onto a waveguide optical bench, requiring no active alignment. We believe this solution will be cost competitive with silicon photonics in the <2km data center market, and it should ultimately be scalable to 10km, as well as support 200G and 400G datacom speeds.

 

In addition to building transceivers, we believe the Company has the opportunity to sell individual components to other suppliers of optical transceivers, including receiver optical sub-assemblies (ROSA), modulators, multiplexers, demultiplexers and single-chip local area network (LAN) wavelength division multiplexing (WDM) lasers.

 

As we continue in the product development phase for both monolithic and hybrid solutions, we are focusing our efforts on meeting specifications for targeted photonic products, starting with active optical cables and 100G transceiver components for the data communications market. Device developments in these areas can also be applied to lower the cost and increase performance of next generation optical sensing products. Product development activities are iterative, and include the optimization of designs, testing the manufacturability and reliability of prototypes, and successfully demonstrating the required scalability and cost parameters. We continue to expect that the product development phase for the POET technology, and for the integration of the BB Photonics technology into the DenseLight product line, will comprise a majority of the 2017 calendar year. As such, we currently expect initial commercial revenues for our new sensing products in 2017, followed by early commercial revenues for our monolithic photonic engine solutions in late 2018.

 

   

 

2 LightCounting Integrated Optical Devices, January 2016

 

 3 
 

 

Revenue was $712,550 for the three months ended March 31, 2017 and gross margin for the period was 41%. We had no revenues in the comparable period in 2016. Our net loss from operations for the period was $3,516,163 compared to a net loss of $2,978,953 for the same period in 2016. Our largest 10 customers comprised approximately 70% of our revenue.

 

Industry Background

 

The two target markets in which we currently sell or plan to sell products near-term are Photonic Sensing and Data Communications. The global photonics market is forecasted to grow at a compound average growth rate (CAGR) of 8% to 12% through 2021, reaching an estimated $54 billion.3 This market includes Photonic Sensing (which consists of devices for test and measurement, navigation, LIDAR systems) and Data Communications (both telecom applications and optical data communications).

 

The Photonics Sensing market4 represents a Total Available Market (“TAM”) of approximately $23 billion and comprises the following segments: 1) Test & Measurement (TAM: $10 billion), which includes monitoring equipment for communication, components and material testing, as well as sensing equipment such as distributed temperature and strain measurement; 2) Structural Health Monitoring (TAM: $6 billion), which includes devices to monitor the power grid, and fiber optic-based sensors in rail lines, nuclear facilities, etc.; 3) Guidance and Navigation (TAM: $4.5 billion), which includes navigational guidance systems, gyrocompasses, and optical-based systems for navigating self-driving automobiles; and 4) Medical and Health Care (TAM: $2.5 billion), which includes devices for non-invasive blood glucose monitoring, pulse-oximeter devices, and ophthalmic examination. We plan to address these high growth markets with a combination of current and expected new products from our DenseLight subsidiary.

 

The growth of the overall Data Communications market is forecasted to grow at a 27% CAGR over the period 2015 to 2020 and is being driven largely by cloud data centers, which have a forecasted CAGR of 29.6% over the same period. This compares to traditional data centers at only a 9% CAGR5. The expected growth in the networking and data communication market is the result of many factors, including smartphone use, over-the-top video consumption, social networking and the “Internet of Things”. Increased consumer demand for data requires both data storage and data communications at higher speeds. As a result, data center operators are increasing the size and scale of their facilities, while simultaneously looking to component suppliers for solutions capable of providing higher data transmission rates. Within data centers, data communications over distances of up to 2 kilometers have already been transitioned from inherently lower speed copper cable to optical fibers. However, short reach communications, either rack-to-rack or within the rack as well as those requiring speeds of up to 100G, are now increasingly being converted from copper to optical cables. We believe that POET is well positioned to address the high-volume short reach market within data centers, by changing the current economics and performance of active optical cable (AOC) with our integrated photonic engine technology.

 

Photonic transceivers will represent a $36 billion market opportunity in 2025, according to Oculi, llc. The primary segments for photonic transceivers are Ethernet, wide area network (WAN) and dense wavelength division multiplexing (DWDM), all of which are predominantly addressed by InP-based optical technologies. Ethernet transceivers are forecasted to grow to $7.4 billion by 2025 with 100G driving a majority of the growth. Within Ethernet, singlemode transceivers based on InP devices are forecasted to outgrow multimode transceivers based on GaAs devices by a factor of 6:1. Segmented by distance, the majority of growth is expected in the <10km segment ($4.3 billion by 2025).6

 

   

 

3 MarketsandMarkets Photonics Market by Application – Global Forecasts to 2012, September 2016

4 Global Market Insights Optical Sensors Market Size By Product, By Application, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024, August 2016

5 Cisco Global Cloud Index, 2015-2020, November 2016

6 Oculi, llc Estimates for 2025 commissioned by POET Technologies, Inc., March 2017

 

 4 
 

 

Our Strategy

 

Our vision is to become a global leader in photonics by deploying both monolithic and hybrid approaches to the integration of photonics devices into a wide variety of vertical market applications. Our strategy includes the following key elements:

 

· Continue our transition from an R&D company to a commercial enterprise based on products and solutions. We will continue to leverage DenseLight’s existing manufacturing and sales capabilities in order to introduce new sensing and datacom products, as well as our integrated POET optical engine once it is fully productized. In addition, we intend to grow revenue from the product families offered by our DenseLight subsidiary, largely through the introduction of new discrete and integrated products based on innovations we have developed internally and acquired from BB Photonics.

 

· Continue technology development cycles for the POET optical engine and initiate product development cycles for our hybrid integrated products from DenseLight. We are fully committed to continuing technology development cycles for the POET optical engine and have made continuous progress in the past six months. We have also made progress in designing novel products at DenseLight using the BB Photonics technology. Product development is an iterative process, involving optimization of designs, testing the manufacturability and reliability of prototypes, and demonstrating required scalability and cost parameters.

 

· Pursue multiple potential sources of non-product revenue and strategic partnerships. In addition to product sales, we have been pursuing Non-Recurring Engineering (“NRE”) revenues from end-use customers and/or from strategic partners. In particular, we believe our 100G transceiver components represent a uniquely attractive opportunity for collaborative development with a strategic partner(s).

 

· Continue to invest in our capabilities and infrastructure. We intend to continue to invest in new products, new technology and our production infrastructure and facilities to maintain and strengthen our competitive position. Our R&D programs in Singapore are partially funded by the Singapore Economic Development Board, whose support will help to defer the costs associated with bringing innovative new products to market.

 

· Selectively pursue other opportunities that leverage our existing expertise. Our expertise in designing and manufacturing photonics devices, both discrete and integrated, positions us well to pursue applications in high growth markets and our Singapore operation is ideally located to support customers in Asia, where much of the growth in photonics is occurring.

 

· Pursue complementary strategic alliance or acquisition opportunities. We intend to evaluate and selectively pursue strategic alliances or acquisition opportunities that we believe will accelerate our penetration of specific applications or vertical markets with our technology or products.

 

 5 
 

 

Our Technology

 

Prior to and since our acquisitions of DenseLight and BB Photonics, we have been focused on a new process for making devices using gallium arsenide (GaAs) as the substrate for wafers. The primary appeal of gallium arsenide is that it’s the most suitable substrate for integrating small-scale integration (SSI) electronics and optics onto a single chip, especially for short reach applications. Optical connections are much faster and more efficient than copper for transferring data within and to/from a chip. The POET photonic engine integrates at least three essential discrete devices onto a single GaAs chip: a vertical-cavity surface-emitting laser (VCSEL), a photodetector and an electronic circuit based on either a thyristor or a heterostructure field-effect transistor (HFET).

 

In addition to the GaAs-based monolithic integration of the POET optical engine, we are pursuing the development of an InP-based 100G optical engine using a hybrid approach to integration. At the core of this development are the active laser components supplied by DenseLight and the novel passive components based on BB Photonics technology. BB Photonics has designed a multi-layer, athermal waveguide and a spot size converter that can be incorporated directly into the InP epitaxial stack. Our objective is to place several integrated and discrete components on a waveguide optical bench that does not require active optical alignment, which would substantially reduce the cost of the device by eliminating the need for lenses and mirrors. We intend to offer both components to transceiver makers, as well as to develop our own 100G, scalable transceiver optical engine.

 

Our Products

 

The GaAs-based POET optical engine may provide the following advantages to the industry:

 

  · Up to 10X power savings improvement over existing copper technologies (especially for high speed data communication links)
  · Up to 5X cost improvement over existing optical component solutions
  · Performance and power of optical solutions at price points competitive to that of copper, thus potentially accelerating the adoption of optical communications solutions
  · Flexible and integrated solution that can be applied to virtually any technical application that commands an optical IO for high bandwidth, including chip-to-chip communications, on-board optics and on-chip optical communications

 

We expect our InP-based solutions, based on DenseLight and BB Photonics technologies, will add to the Company’s current and future product portfolio, including:

 

·Broadband Super-Luminescent LEDs (Light Emitting Diodes)
·Narrow Linewidth Lasers
·DFB (Distributed Feedback) Lasers for Data Communications
·100Gbs ROSA (Receiver Optical Sub-Assemblies) and TOSA (Transmitter Optical Sub-Assemblies) for 100G Transceiver Optical Engines
·High Power ELEDs (Edge Emitting Light Emitting Diodes)
·CWDM (Coarse Wavelength Division Multiplexing) Solutions

 

Intellectual Property

 

We have 51 issued patents and 12 patents pending, including 5 for which allowances have been given by the US Patent Office, all related to the semiconductor Planar Opto-Electronic Technology (“POET”). The patents cover device structures, underlying technology, applications of the technology and fabrication processes. We believe these patents provide a significant barrier to entry against competition, along with trade secrets and know-how acquired from DenseLight and BB Photonics. We intend to continue to apply for additional patents in the future. Currently, we are working on the design of integrated devices, manufacturing processes, and products for data communication applications in the data center market, along with products for photonic sensing markets that employ novel packaging technologies.

 

 6 
 

 

Fabrication and Assembly Capabilities

 

We provide one-stop design and manufacturing solutions, from photonics design and simulation, epitaxial growth, wafer fabrication, chip production, in-line optical coating, sub-mounting, photonic measurements, product tests and screening. We are operationally ready for responsive prototyping and quality production. The 50,000 sq. ft. purpose-built facility in Singapore houses our R&D, product design and manufacturing operations under one roof. Its 15,000 sq. ft. clean room is fully equipped for enabling vertically integrated volume manufacturing, from wafer fabrication to test and packaging. We are ISO9001 certified in Singapore processing Indium Phosphide (InP) and Gallium Arsenide (GaAs) based opto-electronic devices and photonic integrated circuits through our in-house wafer fabrication and assembly & test facilities.

 

We have an experienced team with deep know-how in GaAs and InP semiconductors wafer processing and we continue to build on this technical base. Together with our operationally ready manufacturing and photonics design center, various ODM and design-in programs can be supported for both discrete and integrated optical components.

 

Significant Events and Milestones During 2017

 

In 2017, we continued to execute on our stated strategic plan. We achieved the following significant milestones during Q1 of 2017:

 

1)On January 16, 2017, the Company announced certain organizational changes that included the addition of Rajan Rajgopal as the president and general manager of DenseLight and Soma Sankaran as vice president of sales for the Asia-Pacific region.

 

2)On January 31, 2017, the Company announced the development of micro multiplexer and de-multiplexer solutions. The Company announced that it expects to release in the second half of 2017 a low loss, low cost micro multiplexer and de-multiplexer product for 100G and above transceivers based on the technology developed at its subsidiary BB Photonics Inc. The Company also unveiled its next generation Constellation Series of Narrow Linewidth Laser solutions for test and measurement applications. Introduced specifically to meet superior Relative Intensity Noise (RIN) performance and ultra-narrow linewidths requirements, this new family of products simplifies the overall design process for OEMs, while shortening development time and significantly accelerating time-to-market.

 

3)On February 1, 2017, the Company announced the appointment of David Lazovsky as Executive Chairman of the Board of Directors. Ajit Manocha will remain as a Director on the Board.

 

4)On April 3, 2017, the Company announced that it successfully demonstrated the functionality of the VCSEL for the integrated GaAs opto-electronic platform.

 

 7 
 

 

Summary of Quarterly Results

 

Following are the highlights of financial data of the Company for the most recently completed eight quarters, which have been derived from the Company’s consolidated financial statements prepared in accordance with IFRS:

 

    Mar.31/17   Dec.31/16   Sep.30/16   Jun.30/16   Mar. 1/16   Dec. 31/15   Sep. 30/15   Jun. 30/15
Sales  $712,550   $423,461   $861,545   $576,741   $-   $-   $-   $- 
Cost of sales   419,577    516,247    453,626    409,965    -    -    -    - 
Research and development   858,550    1,104,733    447,019    437,599    530,469    932,618    767,124    715,732 
Depreciation and amortization   540,393    643,344    550,420    239,958    87,844    83,526    82,022    79,587 
Professional fees   155,742    96,009    207,220    272,287    140,200    225,118    110,389    353,892 
Wages and benefits   934,333    586,596    811,035    1,192,887    483,169    414,857    423,214    269,015 
Management and consulting fees   103,931    51,303    230,352    172,401    157,805    156,154    160,303    168,700 
Stock-based compensation (1)   894,813    903,253    1,019,970    887,990    1,259,051    1,491,713    1,621,751    1,110,758 
General expenses and rent   415,666    589,162    373,528    417,224    260,764    353,399    285,802    241,088 
Impairment and other loss   -    29,807    -    -    80,453    -    -    - 
Change in fair values   -    -    (283,130)   -    -    -    -    - 
Other (income), including interest   (19,807)   (19,647)   (11,473)   (14,950)   (20,802)   (20,188)   (18,979)   (22,793)
Net loss before taxes  $3,590,648   $4,077,346   $2,937,022   $3,438,620   $2,978,953   $3,637,197   $3,431,626   $2,915,979 

 

(1)Stock based compensation allocated between General & Administrative and Research & Development issuances are combined for MD&A purposes. For financial statement presentation purposes, stock based compensation is split between General & Administrative and Research & Development.

 

Explanation of Quarterly Results for the three months ended March 31, 2017 ("Q1 2017")

 

Net loss before taxes for Q1 2016, includes the operations of DenseLight and BB Photonics, while the loss for the three months ended March 31, 2016 (“Q1 2016”) reflected the operations of the Company without those subsidiaries, both of which were acquired in Q2 2016. Net loss before taxes for Q1 2017 was $3,590,648 as compared to net loss before taxes of $2,978,953 in Q1 2016. The following discusses the significant variances between Q1 2017 and Q1 2016.

 

During Q1 2017, the Company reported sales of $712,550 through its Denselight subsidiary compared to nil in Q1 2016 (pre-acquisition period).

 

Cost of sales was $419,577 in Q1 2017, which resulted in a gross margin of 41% compared to nil in Q1 2016 (pre-acquisition period).

 

Research and development (“R&D”) increased by 62% or $328,081 from $530,469 in Q1 2016 to $858,550 in Q1 2017. Q1 2017 R&D includes $261,417 and $132,189 of R&D, respectively from both DenseLight and BB Photonics subsidiaries as compared to nil in Q1 2016. The Company has dedicated additional resources to expanding the portfolio of DenseLight products as it has identified opportunities for DenseLight’s sensing products in conjunction with market opportunities for the BB Photonics technology.

 

Professional fees in Q1 2017 increased by 11% or $15,542 from $140,200 in Q1 2016 to $155,742 in Q1 2017. Due to the addition of DenseLight and BB Photonics, the Company’s professional fees have increased, as additional professional services are required, including those for audit-related services.

 

Wages and benefits increased by 93% or $451,164 from $483,169 in Q1 2016 to $934,333 in Q1 2017. The Company experienced some savings in corporate wages and benefits; however, these savings were offset by the inclusion of wages and benefits of DenseLight in Q1 2017 with no comparable DenseLight salaries in Q1 2016 (pre-acquisition period).

 

General expenses and rent increased by 59% or $154,902 from $260,764 in Q1 2016 to $415,666 in Q1 2017. The increased expense is a result of the inclusion of general expenses and rent of DenseLight in Q1 2017 with no comparable DenseLight general expenses and rent in Q1 2016.

 

 8 
 

 

In Q1 2017, management and consulting fees decreased by $53,874 or 34% from Q1 2016. The resignation of Ajit Manocha from the position of Executive Chairman of the Board in February 2017 contributed to the decrease. This reduction in management and consulting fees was partially offset by an increase in wages and benefits of $33,333 for the compensation to the David Lazovsky who replaced Ajit Manocha as the Executive Chairman of the Board. David Lazovsky is paid $200,000 annually in his capacity as Executive Chairman.

 

Non-cash stock-based compensation decreased by $364,238 or 29% from $1,259,051 in Q1 2016 to $894,813 in Q1 2017. The valuation of stock options is driven by a number of factors including the number of options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest. The stock options vest in accordance with the policies determined by the Board of Directors from time to time consistent with the provisions of the 2016 Plan which grants discretion to the Board of Directors.

 

Depreciation and amortization increased by $452,549 or 515% from Q1 2016 to Q1 2017. The expense in Q1 2016 was $87,844 as compared to $540,393 in Q1 2017. The increase was a result of depreciation and amortization relating to the property and equipment, patents and licenses and intangible assets acquired during and after the acquisition of DenseLight and BB Photonics in Q2 2016. The Company acquired $11,030,173 in property and equipment, patents and licenses and intangible assets since Q1 2016.

 

 

Explanation of Material Variations by Quarter for the Last Eight Quarters

 

Q1 2017 compared to Q4 2016

 

Sales in Q1 2017 were $712,550 as compared to $423,461 in Q4 2016. Backlog from 2016 contributed to increased Q1 sales, along with $80,000 of NRE revenue. Gross margins for the quarter were 41% and were compared to the prior period of Q4 2016, which was a negative (10%).

 

R&D decreased by $246,183 or 22% in Q1 2017 from Q4 2016. Development costs of $272,000, which were capitalized in prior periods, were expensed to R&D in Q4 as the Company no longer felt those capitalized costs continued to meet the criteria for capitalization. The Company did not expense any capitalized R&D costs in Q1 2017.

 

Professional fees increased by $59,733 or 62% in Q1 2017 from Q4 2016. Professional fees relating the Company’s year- end audit contributed to the period over period increase.

 

Wages and benefits increased by 59% or $347,737 from Q1 2016 to Q1 2017. Wages and benefits were lower in Q4 2016 due to the reversal of an accrued and unpaid retention bonus of $100,000 to the former COO in Q1 2017. Additionally, Q1 2017 wages and benefits included the wages of the new CFO, the new President of DenseLight, the new VP of Sales for the Asia-Pacific region and the new Executive Chairman of the Board.

 

General expenses and rent decreased by $173,496 or 29% from Q4 2016 to Q1 2017. General expenses were higher in Q4 2016 due to the ancillary costs such as travel and other administrative costs associated with the $9.3 million equity financing in Q4 2016.

 

A reclassification of $75,000 of consulting fees paid to a director in Q4 2016 from management and consulting to the cost of financing resulted in a lower expense of $51,303 in Q4 2016, resulting in the increase of $52,628 or 102%. Management and consulting fees were $103,931 in Q1 2017.

 

Q4 2016 compared to Q3 2016

 

Sales in Q4 2016 were $423,461 as compared to $861,545 in Q3 2016. The reduction in Q4 sales was a result of backlog pushed into Q1 2017 due to production challenges with one large customer. Expected Q4 NRE was also delayed and was not recognized until Q1 2017.

 

R&D expenses increased by $657,714 or 147% from $1,104,733 in Q4 2016 as compared to $447,019 in Q3 2016. Development costs of $272,000, which were capitalized in prior periods, were expensed to R&D in Q4 as the Company no longer felt those capitalized costs continued to meet the criteria for capitalization. Q3 R&D was also limited in scope because of import/export restrictions on its technology. Those restrictions were resolved which resulted in the Company incurring costs in Q4 2016 that would have been incurred more evenly throughout the year.

 

 9 
 

 

Q4 2016 professional fees were $96,009 as compared to $207,220 in Q3 2016. The period over period reduction of $111,211 or 54% was a result of the Company settling most issues in Q3 and earlier periods relating to corporate acquisitions, financing and the recent import/export licensing issues that required professional advisors.

 

Wages and benefits were $586,596 in Q4 2016 and $811,035 in Q3 2016. The reduction of $224,439 or 28% was from cost savings resulting from the 10-20% temporary non-recoverable reduction in US management compensation, a recovery of an accrued but unpaid retention bonus of $100,000 to the former COO and roles that became either vacant or redundant at DenseLight.

 

The reduction in management and consulting fees of $179,049 or 78% from $230,352 in Q3 2016 to $51,303 in Q4 2016 was a result of a 10% to 20% reduction in management fees to head office based executives along with a reclassification of $75,000 of consulting fees paid to a director in Q3 2016. The fees were paid in Q3 2016 and classified as general consulting fees but were reclassified to financing cost in Q4 2016.

 

General expenses and rent increased by $215,635 or 58% from $373,528 in Q3 2016 to $589,162 in Q4 2016. The increase included ancillary costs such as travel and other administrative costs related to the $9.3M financing that was not included as finance costs.

 

Q3 2016 compared to Q2 2016

 

Sales in Q3 2016 were wholly related to the sales of products and services of DenseLight. Sales increased by $284,804 or 49% from $576,741 in Q2 2016 to $861,545 in Q3 2016. The increase in sales also resulted in increased gross margin from 29% in Q2 2016 to 47% in Q3 2016. The increase in gross margin resulted from better absorption of fixed costs with increased revenue.

 

Q3 2016 was the first full quarter since the acquisition of DenseLight and BB Photonics. Depreciation increased by $310,462 or 129% over Q2 2016 from $239,958 to $550,420 due primarily to the depreciation and amortization expense on property and equipment acquired through the acquisition of DenseLight and BB Photonics. The Company also acquired additional property and equipment during Q3 2016. Depreciation on the new property and equipment also contributed to the increase over Q2 2016.

 

Professional fees decreased by $65,067 or 24% from $272,287 in Q2 2016 to $207,220 in Q3 2016. Professional fees in Q2 2016 included the cost of acquiring both DenseLight and BB Photonics. Professional fees in Q3 2016 were also higher due to professional fees incurred in dealing with import and export issues and responding to regulatory inquiries.

 

Wages and benefits decreased by $381,852 or 32% from $1,192,887 in Q2 2016 to $811,035 in Q3 2016. The expense in Q3 2016 reflects a full quarter operating wages of DenseLight that was acquired on May 11, 2016, while representing only a partial quarter in Q2. Q2 2016 wages and benefits included the accrued but unpaid one time executive retention bonuses totaling $550,000 to the CEO and COO that was payable in mid-June 2016 at the one year anniversary date of commencement of the respective employment terms, the amount was voluntarily deferred by them to a future date. The $100,000 bonus to the COO was reversed in Q1 2017.

 

Management and consulting fees of $230,352 in Q3 2016 increased by $57,951 or 34% over $172,401 in Q2 2016. The Q3 2016 expense included $75,000 of fees paid to a director in the normal course of business for strategic, technology, integration and general business consulting services, an expense which was later reclassified to financing costs in Q4 2016.

 

General expenses and rent of $373,528 in Q3 2016 is lower than $417,224 in Q2 2016 by $43,696 or 10%. Although Q3 2016 includes a full quarter of operating costs of DenseLight, the Q2 2016 expense included all the ancillary costs relating to the acquisitions of both DenseLight and BB Photonics.

 

 10 
 

 

Non-cash stock-based compensation increased by $131,980 or 15% from $887,890 in Q2 2016 to $1,019,970 in Q3 2016. The valuation of stock options is driven by a number of factors including the number of options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest. The stock options vest in accordance with the policies determined by the Board of Directors from time to time consistent with the provisions of the 2016 Plan which grants discretion to the Board of Directors.

 

Shareholders of DenseLight were entitled to an additional 1,000,000 shares of the Company if DenseLight met or exceeded a certain revenue target by December 31, 2016. On the date of the acquisition, this contingent consideration was valued at $283,130. As at September 30, 2016, it was determined that DenseLight would not meet the revenue target. The $283,130 of contingent consideration was therefore reclassified to earnings during Q3 2016.

 

Q2 2016 compared to Q1 2016

 

The Company had no sales in Q1 2016. The sales are wholly related to DenseLight that was acquired on May 11, 2016, which led to sales of $576,741 in Q2 2016 versus nil in Q1 2016 (pre-acquisition period).

 

Depreciation and amortization in Q2 2016 was $239,958 as compared to $87,844 in Q1 2016. The increase of $152,114 or 173% over Q1 2016 included $149,723 of depreciation relating to depreciation and amortization expense on new property and equipment resulting from the acquisition of DenseLight and BB Photonics of $8,706,029.

 

Professional fees increased by $132,087 or 94% from $140,200 in Q1 2016 to $272,287 in Q2 2016. The acquisition of DenseLight and BB Photonics contributed to the substantial increase from Q1 2016 to Q2 2016. The Company required the services of various professional consultants including lawyers, accountants and appraisers to complete the acquisition of both companies.

 

Wages and benefits had a substantial increase of $709,718 or 147% from $483,169 in Q1 2016 to $1,192,987 in Q2 2016. The increase was a result of accrued but unpaid executive retention bonuses totaling $550,000 to the CEO and COO that was payable in mid-June 2016, the amount was voluntarily deferred by them to a future date, as well as the inclusion of DenseLight and its wages and benefits of $261,721 for the period from May 11, 2016, acquisition date to the quarter end. The $100,000 bonus to the COO was reversed in Q1 2017.

 

General expenses and rent increased by $156,460 or 60% from $260,764 in Q1 2016 to $417,224 in Q2 2016. DenseLight contributed $74,000 to the increase during the period. The difference resulted from additional costs incurred relating to the acquisition of DenseLight and BB Photonics.

 

Non-cash stock-based compensation decreased by $371,061 or 29% from $1,259,051 in Q1 2016 to $887,990 in Q2 2016. The valuation of stock options is driven by a number of factors including the number of options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest. The stock options vest in accordance with the policies determined by the Board of Directors from time to time consistent with the provisions of the 2015 Plan which grants discretion to the Board of Directors.

 

Q1 2016 compared to Q4 2015

 

R&D decreased by $402,149 or 43% from $932,618 in Q4 2015 to $530,469 in Q1 2016. In Q4 2015, the Company committed to transition to an increased outsourcing model. During Q4 2015, the Company incurred additional upfront costs associated with establishing new foundry and technology development relationships to expedite technology development.

 

Professional fees decreased by $84,918 or 38% from $225,118 in Q4 2015 to $140,200 in Q1 2016. In Q4 2015, the Company paid additional legal fees associated with the expansion of the Company’s patent portfolio coverage in a number of foreign jurisdictions. The Company also spent additional fees on professional services involved in testing the efficiency of the Company’s internal controls as required by the Sarbanes Oxley Act of 2002.

 

 11 
 

 

In Q1 2016, the Company paid a $25,000 performance bonus to the COO. In addition to this payment there was a differential increase of $43,312 in wages and benefits over Q4 2015 was partially due to marginal increase in salaries and higher director fees paid in Q1 2016 than Q4 2015. Cumulative increase in wages and benefits over Q4 2015 was $68,312 or 16% from $414,857 in Q4 2015 to $483,169 in Q1 2016.

 

General expenses decreased by $92,635 or 26% from $353,399 in Q4 2015 to $260,764 in Q1 2016 due primarily to the costs of closing the UConn lab facilities in Q4 2015 and the investor relations and travel costs associated with the Company’s road show in November 2015 to generate interest in the Company and its technology.

 

In Q1 2016, non-cash stock-based compensation of $1,259,051decreased by $232,662 or 16% from $1,491,713 in Q4 2015. This is a result of the timing of stock based compensation expense relative to the vesting date of the historical granted stock options. The valuation of stock options is driven by a number of factors including the quantity of options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest.

 

Q4 2015 compared to Q3 2015

 

In Q4 2015, professional fees of $225,118 increased by $114,729 or 104% over $110,389 in Q3 2015 due to the legal fees incurred relating to the expanded coverage of the Company’s patent portfolio and additional fees related to testing the effectiveness of the Company’s internal controls as required by the Sarbanes Oxley Act.

 

General and administrative increased by $67,597 or 24% from $353,399 in Q4 2015 as compared to $285,802 in Q3 2015 due to the increase in investor relations and travel during the quarter. Additionally, the Company incurred moving and travel costs associated with the closure of the UConn facilities.

 

In Q4 2015, the costs associated with new established foundry and technology development relationships to expedite the technology development were incurred. The Company incurred costs of $449,200 relating to these new parties on the expedited technology work being done as compared to $290,215 in Q3 2015, which accounts for the majority of the $165,494 or 22% increase in R&D expenses from $767,124 in Q3 2015 to $932,618 in Q4 2015.

 

In Q4 2015, non-cash stock-based compensation of $1,491,713 decreased by $130,038 or 8% from $1,621,751 in Q3 2015. This is a result of the timing of stock based compensation expense relative to the vesting date of the historical granted stock options. The valuation of stock options is driven by a number of factors including the quantity of options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest.

 

Q3 2015 compared to Q2 2015

 

In Q3 2015, professional fees of $110,389 decreased by $243,503 or 69% from $353,892 in Q2 2015. The Company successfully recruited two executive officers (CEO and COO). The Company paid $200,000 in recruitment fees related to their employment in Q2 2015. Both executives were appointed in June 2015. No recruitment fees were paid in Q3 2015.

 

Wages and benefits increased by $154,199 or 57% from $269,015 in Q2 2015 to $423,214 in Q3 2015 due to the addition of the new CEO and COO. Wages and benefits will be higher over the short term as the transition of responsibilities continues from the former interim CEO to the new CEO as both salaries are incurred by the company in the transition period.

 

Non-cash stock-based compensation of $1,621,751 in Q3 2015 was $510,993 or 46% higher than the expense of $1,110,758 in Q2 2015. The increase was impacted by timing of the expense related to the 10,430,000 stock options granted throughout calendar 2015. The Company granted 7,857,000 stock options to new executives (CEO and COO). The valuation of stock options is driven by a number of factors including the quantity of options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest.

 

 12 
 

 

Segment Disclosure

 

The Company and its subsidiaries operate in a single segment; the design, manufacture and sale of semi-conductor products and services for commercial applications. The Company’s operating and reporting segment reflects the management reporting structure of the organization and the manner in which the chief operating decision maker regularly assesses information for decision making purposes, including the allocation of resources. A summary of the Company's operations is below:

 

ODIS Inc. (“ODIS”)

Odis is the developer of the POET platform semiconductor process IP for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single die.

 

BB Photonics

 

BB Photonics develops photonic integrated components for the datacenter market utilizing embedded dielectric technology that is intended to enable on-chip athermal wavelength control and lower the total solution cost of datacenter photonic integrated circuits.

 

DenseLight

 

DenseLight designs, manufactures, and delivers photonic optical light source products and solutions to the communications, medical, instrumentations, industrial, defense, and security industries. DenseLight processes compound semiconductor-based optoelectronic devices and photonic integrated circuits through its in-house wafer fabrication and assembly & test facilities.

 

The Company operates geographically in the United States, Canada and Singapore. Geographical information is as follows:

 

   2017
As of March 31,  Singapore  US  Canada  Consolidated
             
Current assets  $2,308,960   $8,547,731   $3,032,420   $13,889,111 
Property and equipment   8,600,712    367,006    2,300    8,970,018 
Patents and licenses   -    442,313    -    442,313 
Goodwill and intangibles assets   7,076,842    1,471,719    -    8,548,561 
                     
Total Assets  $17,986,514   $10,828,769   $3,034,720   $31,850,003 

 

 

Three Months Ended March 31,  Singapore  US  Canada  Consolidated
             
Sales  $(712,550)  $-   $-   $(712,550)
Cost of sales   419,577    -    -    419,577 
Selling, marketing and administration   1,225,509    1,499,784    228,168    2,953,461 
Research and development   291,105    608,052    50,810    949,967 
Impairment loss   -    -    -    - 
Loss on disposal of property and equipment   -    -    -    - 
Other income including                    
Investment income   (11,742)   -    (8,065)   (19,807)
                     
Net loss from operations  $1,211,899   $2,107,836   $270,913   $3,590,648 

 

 

   2016
As of December 31,  Singapore  US  Canada  Consolidated
             
Current assets  $2,118,561   $10,058,018   $4,957,624   $17,134,203 
Property and equipment   9,039,069    322,633    2,508    9,364,210 
Patents and licenses   -    449,676    -    449,676 
Goodwill and intangible assets   7,086,149    1,471,719    -    8,557,868 
                     
Total Assets  $18,243,779   $12,302,046   $4,960,132   $35,505,957 

 

 13 
 

 

 

For the three months ended March 31,  Singapore  US  Canada  Consolidated
             
General and administration  $-   $1,843,363   $406,120   $2,249,483 
Research and development   -    669,819    -    669,819 
Impairment loss   -    63,522    -    63,522 
Loss on disposal of property and equipment   -    -    16,931    16,931 
Other income   -    -    (20,802)   (20,802)
                     
Net loss from operations  $-   $2,576,704   $402,249   $2,978,953 

 

 

Liquidity and Capital Resources

 

The Company had working capital of $13,340,299 on March 31, 2017 as compared to $15,509,859 on December 31, 2016.

 

The Company’s balance sheet as of March 31, 2017 reflects assets with a book value of $31,850,003, compared to $35,505,597 as of December 31, 2016. Forty-three percent (43%) of the book value, or $13,889,111, was in current assets consisting primarily of cash and short-term investments, compared to 48%, or $ $17,134,203 as of December 31, 2016.

 

Acquisitions

 

DenseLight

On May 11, 2016, the Company acquired all the issued and outstanding shares of DenseLight, a designer, manufacturer and provider of photonic sensing and optical light source products for consideration of $10,500,000. The all-stock purchase was accomplished with the issuance of 13,611,150 common shares of the Company at a price of $0.7714 per share. The Company also committed to issuing shares representing $1,000,000 to the sellers in the event that DenseLight met or exceeded a pre-determined revenue target during calendar 2016. The revenue targets have not been met.

 

This acquisition provides the Company with direct and preferred access to a fab infrastructure for future product development, access to product sales and channel distribution networks and a broader product portfolio of photonic products, technology and know-how.

 

Upon closing the acquisition, the Company negotiated a settlement agreement relating to obligations that were due to past or current employees of DenseLight. As part of the settlement agreement, the Company issued 1,738,236 common shares at a price of $0.7714 per share for a total of $1,343,629. The Company also paid $240,266 to current and past employees as part of the debt settlement. Accounts payable and accrued liabilities include $184,570 still due to past and current employees that will be paid over the next 6 months.

 

The Company also settled a loan of $500,000 owing to EDB Investments Pte. Ltd., an investor in DenseLight, with the issuance of 648,150 shares at a price of 0.771 per share.

 

Former management shareholders of DenseLight agreed not to sell, transfer, pledge or otherwise dispose of the shares of the Company for a period of six months, at which time they may each sell up to 25% of their shares. They may sell an additional 25% of the shares after twelve months. These restrictions expire on May 11, 2017. Thereafter, all management shareholders shall be able to sell the remaining shares after 24 months from closing. Former non-management shareholders of DenseLight agreed not to sell, transfer, pledge or otherwise dispose of the shares they received for six months, at which time they may sell up to 25% of the shares received. Thereafter, they may sell the remaining shares after 12 months from closing. These restrictions expire on May 11, 2017.

 

 14 
 

 

On acquisition, DenseLight held accounts receivable and unbilled revenue in the amount of $198,898 that reflected their fair value. The Company does not expect that there will be any unrealized contractual cash flows. The billed receivables at closing have been subsequently collected.

 

The acquisition has been accounted for using the acquisition method of accounting. Acquisition related costs of $197,284 were expensed in the year and included in selling, marketing and administrative expenses.

 

Fair value of consideration paid

 

Fair value of 13,611,150 shares issued  $10,500,000 
Contingent consideration payable   283,130 
      
Total consideration  $10,783,130 
      
      
Recognised amounts of identifiable net assets:     
      
Cash  $2,971 
Accounts receivables and unbilled revenue   198,898 
Prepaid and other current assets   293,386 
Inventory   319,257 
Property and equipment   8,635,650 
Customer relationships   186,131 
Goodwill   6,630,544 
Trade payables   (2,979,546)
Loans and advances   (1,000,000)
Deferred tax liability   (1,504,161)
      
Net assets acquired  $10,783,130 

 

Loans and advances include $500,000 that was advanced to DenseLight by the Company prior to its acquisition. This advance was used by DenseLight to cover the expenses required for the development under the Development Services Agreement between DenseLight and the Company, based on the special pricing negotiated between the parties.

 

The purchase and sale agreement provides for an additional $1,000,000 worth of shares to be issued to the sellers should gross revenue from DenseLight exceed certain targets for 2016. The fair value of this contingent consideration payable is determined by estimating the probability of the Company making that future payment and then discounting it to present value using a discount rate of 9% being the estimated cost of debt for the Company. At December 31, 2016, DenseLight did not exceed the established revenue targets for 2016. The Company has therefore adjusted the fair value of contingent consideration to nil through earnings.

 

A deferred tax liability of $1,504,161 was created on the date of purchase relating to the fair value adjustment of the assets acquired. The change in the fair value of assets acquired arising from amortization or the sale of assets resulted in a deferred tax recovery of $207,257. Deferred tax liability relating to the DenseLight acquisition at March 31, 2017 was $1,229,082.

 

 15 
 

 

BB Photonics

On June 22, 2016, the Company acquired all the issued and outstanding shares of BB Photonics, a designer of integrated photonic solutions for the data communications market for consideration of $1,550,000. The all-stock purchase was accomplished with the issuance of 1,996,090 common share of the Company at a price of $0.777 per share.

 

The acquisition of BB Photonics provides the Company with additional differentiated intellectual property and know-how for product development, which will enable the Company to better reach its first identified commercial market, the end-to-end data communications market, as well as to augment its sensing roadmap.

 

The acquisition has been accounted for using the acquisition method of accounting. Acquisition related costs of $59,930 were expensed in the year and included in selling, marketing and administrative expenses.

 

Fair value of consideration paid

 

Fair value of 1,996,090 shares issued  $1,550,000 
      
Recognised amounts of identifiable net assets:     
      
Cash  $15,820 
Property and equipment   70,379 
Intangibles   714,000 
Goodwill   1,050,459 
Trade payables   (7,918)
Deferred tax liability   (292,740)
      
Net assets acquired  $1,550,000 

 

A deferred tax liability of $292,740 was created on the date of acquisition and related to the value of the In-Process Research and Development (IPR&D).  Externally generated IPR&D is subject to impairment whenever events or changes indicate that its carrying amount may not be recoverable.  Since the Company is still in the process of completing its technology and related products, the IPR&D and related deferred tax liability has not been impaired or amortized.

 

 16 
 

 

Related Party Transactions

 

Compensation to key management personnel was as follows:

 

   Three Months Ended
March 31,
   2017  2016
       
Salaries   268,633    554,290 
Share-based payments (1)   723,453    908,463 
           
Total   992,086    1,462,753 

 

(1) Share-based payments are the fair value of options granted to key management personnel and expensed during the various periods as calculated using the Black-Scholes model.

 

The Company paid or accrued $28,313 in fees for the three months ended March 31, 2017 (Q1 2016 - $27,337) to a law firm, of which a director is counsel, for legal services rendered to the Company. During the period ended March 31, 2017, the Company paid the final installment of $25,000 on a total of $150,000 of consulting fees to a director which were charged against the financing concluded on November 2, 2016.

 

All transactions with related parties have occurred in the normal course of operations and are measured at the exchange amounts, which are the amounts of consideration established and agreed to by the related parties.

 

Critical Accounting Estimates

 

Accounts receivable

 

Accounts receivable are amounts due from customers from the sale of products or services in the ordinary course of business. Accounts receivables are classified as current (on the consolidated statements of financial position) if payment is due within one year of the reporting period date, and are initially recognized at fair value and subsequently measured at amortized cost.

 

The provision policy for doubtful accounts of the Company is based on the ageing analysis and management's ongoing evaluation of the recoverability of the outstanding receivables. A considerable amount of judgment is required in assessing the ultimate realization of these receivables, including the assessment of the creditworthiness and the past collection history of each customer. If the financial conditions of these customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. As at the balance sheet date, no provision was required for accounts receivable.

 

Inventory

 

Inventory consist of raw material inventory, work in process, and finished goods and are recorded at the lower of cost and net realizable value. Cost is determined on a first in first out basis and includes all costs of purchase, costs of conversion and other costs incurred in bringing the inventory to its present condition.

 

An assessment is made of the net realizable value of inventory at each reporting period. Net realizable value is the estimated selling price less the estimated cost of completion and the estimated costs necessary to make the sale. When circumstances that previously caused inventory to be written down no longer exist or when there is clear evidence of an increase in net realizable value because of changed economic circumstances, the amount of any write down previously recorded is reversed so that the new carrying amount is the lower of the cost and the revised net realizable value. Raw materials are not written down unless the goods in which they are incorporated are expected to be sold for less than cost, in which case, they are written down by reference to replacement cost of the raw materials, as this is the best indicator of net realizable value.

 

 17 
 

 

Property and equipment

 

Property and equipment are recorded at cost. Depreciation is calculated based on the estimated useful life of the asset using the following method and useful lives:

 

Machinery and equipment  Straight Line, 5 years
Leasehold improvements Straight Line, 5 years or life of the lease, whichever is less
Office equipment  Straight Line, 5 years

 

Patents and licenses

 

Patents and licenses are recorded at cost and amortized on a straight-line basis over 12 years. Ongoing maintenance costs are expensed as incurred.

 

Intangible assets

 

Internally generated intangible assets are recorded at cost and will be amortized on a straight-line basis based on the best estimate of the useful life of the asset developed from the point at which the asset is ready for use. Internally generated intangible assets are tested for impairment whenever events or changes indicate that its carrying amount may not be recoverable. Externally acquired intangible assets are amortized on a straight-line basis over 5 years commencing when the asset is ready for use. Externally generated intangible assets are tested for impairment whenever events or changes indicate that its carrying amount may not be recoverable

 

Stock-based Compensation

 

Stock options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Stock options and warrants awarded to employees are accounted for using the fair value method. The fair value of such stock options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.

 

Other stock-based payments

 

The Company accounts for other stock-based payments based on the fair value of the equity instruments issued or service provided, whichever is more reliable.

 

Cumulative Translation Adjustment

 

IFRS requires certain gains and losses such as certain exchange gains and losses arising from the translation of the financial statements of a self-sustaining foreign operation to be included in comprehensive income.

 

Recent Accounting Pronouncements

 

The Company has considered all recently issued accounting pronouncements and does not believe the adopting of such pronouncements will have a material impact on its consolidated financial statements. Please see note 3 of the financial statements for additional information.

 

Financial Instruments and Risk Management

 

The Company's financial instruments consist of cash, short-term investments, accounts receivable, non-current assets held for sale, accounts payable and accrued liabilities and contingent consideration payable. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest risk arising from these financial instruments. The Company estimates that the fair value of these instruments approximates fair value due to their short-term nature.

 

Exchange Rate Risk

 

The Company is exposed to foreign currency risk with the Canadian dollar and Singapore dollar. The Company maintains bank accounts and cash reserves in three currencies with the majority of reserves currently in Canadian dollars, which has exposure to currency fluctuations. Most of the Company’s operations are transacted in US dollars and Singapore Dollars. A 10% change in the Canadian dollar and Singapore dollar would increase or decrease other comprehensive loss by $490,235.

 

 18 
 

 

Interest Rate Risk

 

Cash equivalents bear interest at fixed rates, and as such, are subject to interest rate risk resulting from changes in fair value from market fluctuations in interest rates. The Company does not depend on interest from its investments to fund its operations.

 

Credit Risk

 

The Company is exposed to credit risk associated with its accounts receivable. The Company has accounts receivable from both governmental and non-governmental agencies. Credit risk is minimized substantially by ensuring the credit worthiness of the entities with which it carries on business. Credit terms are provided on a case-by-case basis. The Company has not experienced any significant instances of non-payment from its customers.

 

The Company's accounts receivable ageing at March 31, 2017 was as follows:

 

   March 31,
2017
    
Current  $103,793 
31 - 60 days   244,837 
61 - 90 days   17,010 
> 90 days   52,068 
      
   $417,708 

 

World Economic Risk

 

Like many other companies, the world economic climate could have an impact on the Company's business and the business of many of its current and prospective customers. A slump in demand for electronic-based devices, due to a world economic crisis, may impact any anticipated licensing revenue.

 

Obsolescence Risk

 

The Company designs, manufactures and sells various highly technological electronic products that could become obsolete should lower priced competitors or new technology enter the market. This would expose the company to obsolescence risk in inventory balances, but also a risk of obsolescence in the product offering. The redesign of the product offering could take significant time or could never occur.

 

Liquidity Risk

 

The Company predominately relies on equity funding for liquidity to meet current and foreseeable financial requirements.

 

 19 
 

 

Strategy and Outlook

 

There are a number of projects planned for the remainder of 2017 that the Company expects will address the short-term and long-term growth plans of the Company including, but not limited to the following:

 

· Continue our transition from an R&D company to a commercial enterprise based on products and solutions;

 

· Continue technology development cycles for the POET optical engine and initiate product development cycles for our hybrid integrated products from DenseLight;

 

· Pursue multiple potential sources of non-product revenue and strategic partnerships;

 

· Continue to invest in our capabilities and infrastructure;

 

· Selectively pursue other opportunities that leverage our existing expertise; and

 

· Pursue complementary strategic alliance or acquisition opportunities.

 

Outstanding Share Data

 

Common Shares

 

As of March 31, 2017 and May 11, 2017, there were 259,333,853 and 259,923,852 outstanding common shares of the Company.

 

Stock Options and Warrants

 

As of March 31, 2017 and May 11, 2017, there were 34,800,000 warrants outstanding to purchase common shares at an exercise price of CA$0.52.

 

Total stock options outstanding as at March 31, 2017 and May 11, 2017 were 27,680,500 and 25,315,500 priced between CA$0.23 and CA$1.99 per common share.

 

Additional detailed share data information is available in the Company’s Notes to Consolidated Financial Statement.

 

Off-Balance Sheet Arrangements

 

The Company has not entered into any off-balance sheet arrangements.

 

Key Business Risks and Uncertainties

 

The process of developing new, technologically advanced products in semiconductor manufacturing and photonics products is highly complex and uncertain, and we cannot guarantee a positive result.

 

The development of new, technologically advanced products is a complex and uncertain process requiring frequent innovation, highly-skilled engineering and development personnel and significant capital, as well as the accurate anticipation of technological and market trends. We cannot assure you that we will be able to identify, develop, manufacture, market or support new or enhanced products successfully or on a timely basis. Further, we cannot assure you that our new products will gain market acceptance or that we will be able to respond effectively to product introductions by competitors, technological changes or emerging industry standards. We also may not be able to develop the underlying core technologies necessary to create new products and enhancements, license these technologies from third parties, or remain competitive in our markets.

 

 20 
 

 

Customer demand is difficult to forecast accurately and, as a result, we may be unable to match production with customer demand.

 

We make planning and spending decisions, including determining the levels of business that we will seek and accept, production schedules, component procurement commitments, personnel needs and other resource requirements, based on our estimates of product demand and customer requirements. Our products are typically sold pursuant to individual purchase orders. While our customers may provide us with their demand forecasts, they are typically not contractually committed to buy any quantity of products beyond firm purchase orders. Furthermore, many of our customers may increase, decrease, cancel or delay purchase orders already in place without significant penalty. The short-term nature of commitments by our customers and the possibility of unexpected changes in demand for their products reduce our ability to accurately estimate future customer requirements. If any of our customers decrease, stop or delay purchasing our products for any reason, we will likely have excess manufacturing capacity or inventory and our business and results of operations would be harmed.  

 

If our customers do not qualify our products for use on a timely basis, our results of operations may suffer. 

 

Prior to the sale of new products, our customers typically require us to “qualify” our products for use in their applications. At the successful completion of this qualification process, we refer to the resulting sales opportunity as a “design win.” Additionally, new customers often audit our manufacturing facilities and perform other evaluations during this qualification process. The qualification process involves product sampling and reliability testing and collaboration with our product management and engineering teams in the design and manufacturing stages. If we are unable to accurately predict the amount of time required to qualify our products with customers, or are unable to qualify our products with certain customers at all, then our ability to generate revenue could be delayed or our revenue would be lower than expected and we may not be able to recover the costs associated with the qualification process or with our product development efforts, which would have an adverse effect on our results of operations.

 

The markets in which we operate are highly competitive, which could result in lost sales and lower revenues.

 

The market for optical components and modules is highly competitive and this competition could result in our existing customers moving their orders to our competitors. We are aware of a number of companies that have developed or are developing optical component products, including LEDs, lasers, pluggable components, modules and subsystems, among others, that compete directly with our current and proposed product offerings.

 

Some of our current competitors, as well as some of our potential competitors, have longer operating histories, greater name recognition, broader customer relationships and industry alliances and substantially greater financial, technical and marketing resources than we do. We may not be able to compete successfully with our competitors and aggressive competition in the market may result in lower prices for our products and/or decreased gross margins. Any such development could have a material adverse effect on our business, financial condition and results of operations.

 

Our products, including those sold by predecessor company, OPEL Solar, could contain defects that may cause us to incur significant costs or result in a loss of customers or subject us to claims for which we may not be fully insured.

 

Our predecessor company, Opel Solar, sold solar systems and products between 2007 and 2012, and some of those products may still be under warranty. We have not undertaken to quantify the size of that warranty obligation and it is not recorded on our balance sheet because it is not determinable. Although we carry product liability insurance, this insurance may not adequately cover our costs arising from defects or warranty claims related to those products.

 

 21 
 

 

Our current products sold by DenseLight are complex and undergo quality testing as well as formal qualification by our customers. Our customers’ testing procedures are limited to evaluating our products under likely and foreseeable failure scenarios and over varying amounts of time. For various reasons, such as the occurrence of performance problems that are unforeseeable in testing or that are detected only when products age or are operated under peak stress conditions, our products may fail to perform as expected long after customer acceptance. Failures could result from faulty components or design, problems in manufacturing or other unforeseen reasons. As a result, we could incur significant costs to repair or replace defective products under warranty, particularly when such failures occur in installed systems. Our products are typically embedded in, or deployed in conjunction with, our customers’ products, which incorporate a variety of components, modules and subsystems and may be expected to interoperate with modules produced by third parties. As a result, not all defects are immediately detectable and when problems occur, it may be difficult to identify the source of the problem. While we have not experienced material failures in the past, we will continue to face this risk going forward because our products are widely deployed in many demanding environments and applications worldwide. In addition, we may in certain circumstances honor warranty claims after the warranty has expired or for problems not covered by warranty to maintain customer relationships. Any significant product failure could result in litigation, damages, repair costs and lost future sales of the affected product and other products, divert the attention of our engineering personnel from our product development efforts and cause significant customer relations problems, all of which would harm our business. Although we carry product liability insurance, this insurance may not adequately cover our costs arising from defects in our products or otherwise.

 

The business that we acquired did not have a history of profitable operations. Our ability to successfully manage our manufacturing operations is essential to our overall success, and if we fail to do so, our financial results will suffer.

 

At the time of the acquisition of DenseLight Semiconductors, Pte. Ltd. in May of 2016, the company had been operating at a loss for several years and was at a minimum staffing level. Since the acquisition we have committed substantial capital and management attention to improving the operation, increasing sales and driving to profitability. Even though substantial changes in the management and personnel have been made, the results to date have been less than anticipated and more improvement will be required in order to make the DenseLight operation profitable. We cannot guarantee that our efforts to improve the DenseLight operation will be successful, and if they are not, the operation will continue to need capital and attention from the senior management of the company and our financial results may suffer as a result.

 

If we encounter manufacturing problems or if manufacturing at our Singapore operation is discontinued for any reason, including an industrial or workplace accident, we may lose sales and damage our customer relationships, or be subject to claims for which we may not be fully insured.

 

We may experience delays, disruptions or quality control problems in our manufacturing operations. These and other factors may cause less than acceptable yields at our wafer fabrication facility. Manufacturing yields depend on a number of factors, including the quality of available raw materials, the degradation or change in equipment calibration and the rate and timing of the introduction of new products. Changes in manufacturing processes required as a result of changes in product specifications, changing customer needs and the introduction of new products may significantly reduce our manufacturing yields, resulting in low or negative margins on those products. In addition, because of our wafer size, we use equipment that is not readily available on the open market and for which spare parts and qualified service people may not be available. If any of our key equipment were to be damaged or destroyed for any reason, our manufacturing process would be severely disrupted. Any such manufacturing problems would likely delay product shipments to our customers, which would negatively affect our sales, competitive position and reputation.

 

Our operations in Singapore are subject to government regulations that protect the workplace safety of employees. We strive to maintain an accident-free workplace, but we cannot guarantee that industrial accidents will not take place, or that we will not be subject to liability for these and other workplace related claims. We have obtained insurance policies to protect the company against claims for workplace related claims, but we cannot guarantee that these and other insurance policies carried by the Company will be sufficient to cover the full costs of such claims, which could have a material adverse effect on the Company.

 

 22 
 

 

We have limited operating history in the AOC market, and our business could be harmed if this market does not develop as we expect.

 

The initial target market for our GaAs-based photonic engine is the Active Optical Cable (AOC) market and we have no experience in selling products in this market. We may not be successful in developing a product for this market and even if we do, it may never gain widespread acceptance by large data center operators. If our expectations for the growth of the AOC market are not realized, our financial condition or results of operations may be adversely affected.

 

We depend on a limited number of suppliers and key contract manufacturers who could disrupt our business and technology development activities if they stopped, decreased, delayed or were unable to meet our demand for shipments of their products or manufacturing of our products.

 

We depend on a limited number of suppliers of epitaxial wafers and contract manufacturers for both our GaAs and InP development and production activities. Some of these suppliers are sole source suppliers. We typically have not entered into long-term agreements with our suppliers. As a result, these suppliers generally may stop supplying us materials and other components at any time. Our reliance on a sole supplier or limited number of suppliers could result in delivery problems, reduced control over technology development, product development, pricing and quality, and an inability to identify and qualify another supplier in a timely manner. Some of our suppliers that may be small or under-capitalized may experience financial difficulties that could prevent them from supplying us materials and other components. In addition, our suppliers, including our sole source suppliers, may experience manufacturing delays or shut downs due to circumstances beyond their control such as earthquakes, floods, fires, labor unrest, political unrest or other natural disasters.

 

Any supply deficiencies relating to the quality or quantities of materials or equipment we use to manufacture our products could materially and adversely affect our ability to fulfill customer orders and our results of operations. Lead times for the purchase of certain materials and equipment from suppliers have increased and in some cases have limited our ability to rapidly respond to increased demand, and may continue to do so in the future. To the extent we introduce additional contract manufacturing partners, introduce new products with new partners and/or move existing internal or external production lines to new partners, we could experience supply disruptions during the transition process. In addition, due to our customers’ requirements relating to the qualification of our suppliers and contract manufacturing facilities and operations, we cannot quickly enter into alternative supplier relationships, which prevents us from being able to respond immediately to adverse events affecting our suppliers.

 

Our international business and operations expose us to additional risks.

 

Products shipped to customers located outside Canada and the United States account for a majority of our revenues. In addition, we have significant tangible assets located outside the United States. Our manufacturing facilities are located in Singapore. Conducting business outside Canada and the United States subjects us to a number of additional risks and challenges, including:

 

   • periodic changes in a specific country's or region's economic conditions, such as recession;
   • licenses and other trade barriers; 
   • the provision of services may require export licenses;
   • environmental regulations;

 

 23 
 

 

   • certification requirements;
   • fluctuations in foreign currency exchange rates;
   • inadequate protection of intellectual property rights in some countries;
   • preferences of certain customers for locally produced products;
   • potential political, legal and economic instability, foreign conflicts, and the impact of regional and global infectious illnesses in the countries in which we and our customers, suppliers and contract manufacturers are located;
   • Canadian and U. S. and foreign anticorruption laws;
   • seasonal reductions in business activities in certain countries or regions; and
   • fluctuations in freight rates and transportation disruptions.

 

These factors, individually or in combination, could impair our ability to effectively operate one or more of our foreign facilities or deliver our products, result in unexpected and material expenses, or cause an unexpected decline in the demand for our products in certain countries or regions. Our failure to manage the risks and challenges associated with our international business and operations could have a material adverse effect on our business.

 

If we fail to attract and retain key personnel, our business could suffer.

 

Our future success depends, in part, on our ability to attract and retain key personnel, including executive management. Competition for highly skilled technical personnel is extremely intense and we may face difficulty identifying and hiring qualified engineers in many areas of our business. We may not be able to hire and retain such personnel at compensation levels consistent with our existing compensation and salary structure. Our future success also depends on the continued contributions of our executive management team and other key management and technical personnel, each of whom would be difficult to replace. The loss of services of these or other executive officers or key personnel or the inability to continue to attract qualified personnel could have a material adverse effect on our business.

 

Our prior acquisitions created a large amount of goodwill, which may have to be impaired in the future and as a result may adversely affect our financial results. In addition, past and any future acquisitions may adversely affect our financial condition and results of operations.

 

As part of our business strategy, we have in the past and may in the future pursue acquisitions of companies that we believe could enhance or complement our current product portfolio, augment our technology roadmap or diversify our revenue base. Acquisitions involve numerous risks, any of which could harm our business, including: 

 

   • difficulties integrating the acquired business;
   • unanticipated costs, capital expenditures, liabilities or changes to product development efforts;
   • difficulties integrating the business relationships with suppliers and customers of the acquired business with our existing operations;
   • acts or omissions by the acquired company prior to the acquisition that may subject us to unknown risks or liabilities;
   • risks associated with entering markets in which we have little or no prior experience; 

 

 24 
 

 

   • potential loss of key employees, particularly those of the acquired organizations; and 
   • diversion of financial and management resources from our existing business;

 

Our prior acquisitions have resulted, and future acquisitions may result in the recording of goodwill and other intangible assets subject to potential impairment in the future, adversely affecting our operating results. We may not achieve the anticipated benefits of an acquisition if we fail to evaluate it properly, and we may incur costs in excess of what we anticipate. A failure to evaluate and execute an acquisition appropriately or otherwise adequately address these risks may adversely affect our financial condition and results of operations. 

 

Our predecessor company received and our current companies receive and expect to receive in the future subsidies and other types of funding from government agencies in the locations in which we operate. The funding agreements stipulate that if we do not comply with various covenants, including eligibility requirements, and/or do not achieve certain pre-defined objectives, those government agencies may reclaim all or a portion of the funding provided. If this were to occur, we would either not be in a position to repay the claimed amounts or would have to borrow large sums in order to do so, which would adversely affect our financial condition.

 

Our predecessor company Opel Solar, received research and development grants from the United States Air Force and from NASA; our recently acquired subsidiary company, DenseLight Semiconductor, Pte, Ltd. is expected to receive funding for new product development activities conducted in Singapore from the Economic Development Board; and we expect that our recently acquired subsidiary company BB Photonics U.K., may also apply for certain grants to defer the cost of development in the U.K. The rules for eligibility vary widely across government agencies, are complex and may be subject to different interpretations. Furthermore, some of the grants set pre-defined development or spending objectives, which we may not achieve. We cannot guarantee that one or more agencies will not seek repayment of all or a portion of the funds provided, and if this were to occur, we would have to borrow large sums in order to make the repayments, which would adversely affect our financial condition.

 

We may be subject to disruptions or failures in information technology systems and network infrastructures that could have a material adverse effect on our business and financial condition.

 

We rely on the efficient and uninterrupted operation of complex information technology systems and network infrastructures to operate our business. A disruption, infiltration or failure of our information technology systems as a result of software or hardware malfunctions, system implementations or upgrades, computer viruses, third-party security breaches, employee error, theft or misuse, malfeasance, power disruptions, natural disasters or accidents could cause a breach of data security, loss of intellectual property and critical data and the release and misappropriation of sensitive competitive information and partner, customer, and employee personal data. Any of these events could harm our competitive position, result in a loss of customer confidence, cause us to incur significant costs to remedy any damages and ultimately materially adversely affect our business and financial condition.

 

We have a history of large operating losses. We may not be able to sustain profitability in the future and as a result we may not be able to maintain sufficient levels of liquidity.

 

We have historically incurred losses and negative cash flows from operations since our inception. As of March 31, 2017, we had an accumulated deficit of $107,591,519. For the three months March 31, 2017 and March 31, 2016, we incurred losses from operations before income taxes of $3,590,648 and $2,978,953 respectively.

 

As of March 31, 2017, we held $11,671,458 in cash and short-term investments, and we had working capital of $13,340,299.

 

 25 
 

 

The optical communications industry is subject to significant operational fluctuations. In order to remain competitive we incur substantial costs associated with research and development, qualification, production capacity and sales and marketing activities in connection with products that may be purchased, if at all, long after we have incurred such costs. In addition, the rapidly changing industry in which we operate, the length of time between developing and introducing a product to market, frequent changing customer specifications for products, customer cancellations of products and general down cycles in the industry, among other things, make our prospects difficult to evaluate. As a result of these factors, it is possible that we may not (i) generate sufficient positive cash flow from operations; (ii) raise funds through the issuance of equity, equity-linked or convertible debt securities; or (iii) otherwise have sufficient capital resources to meet our future capital or liquidity needs. There are no guarantees we will be able to generate additional financial resources beyond our existing balances.

 

We may not be able to obtain additional capital when desired, on favorable terms or at all.

 

We operate in a market that makes our prospects difficult to evaluate and, to remain competitive, we will be required to make continued investments in capital equipment, facilities and technology. We expect that substantial capital will be required to continue technology and product development, to expand our manufacturing capacity if we need to do so and to fund working capital for anticipated growth. If we do not generate sufficient cash flow from operations or otherwise have the capital resources to meet our future capital needs, we may need additional financing to implement our business strategy.

 

If we raise additional funds through the issuance of our common stock or convertible securities, the ownership interests of our stockholders could be significantly diluted. These newly issued securities may have rights, preferences or privileges senior to those of existing stockholders. Additional financing may not, however, be available on terms favorable to us, or at all, if and when needed, and our ability to fund our operations, take advantage of unanticipated opportunities, develop or enhance our infrastructure or respond to competitive pressures could be significantly limited. If we cannot raise required capital when needed, including under our Short Form Prospectus filed with the Canadian Securities Exchange and the U.S. SEC in October 2016, we may be unable to continue technology and product development, meet the demands of existing and prospective customers, adversely affecting our sales and market opportunities and consequently our business, financial condition and results of operations.

 

Our business could be negatively impacted as a result of shareholder activism.

 

In recent years, shareholder activists have become involved in numerous public companies. Shareholder activists frequently propose to involve themselves in the governance, strategic direction, and operations of the company. We may in the future become subject to such shareholder activity and demands. Such demands may disrupt our business and divert the attention of our management and employees, and any perceived uncertainties as to our future direction resulting from such a situation could result in the loss of potential business opportunities, be exploited by our competitors, cause concern to our current or potential customers, and make it more difficult to attract and retain qualified personnel and business partners, all of which could adversely affect our business. In addition, actions of activist shareholders may cause significant fluctuations in our stock price based on temporary or speculative market perceptions or other factors that do not necessarily reflect the underlying fundamentals and prospects of our business. 

 

If we fail to protect, or incur significant costs in defending, our intellectual property and other proprietary rights, our business and results of operations could be materially harmed.

 

Our success depends on our ability to protect our intellectual property and other proprietary rights. We rely on a combination of patent, trademark, copyright, trade secret and unfair competition laws, as well as license agreements and other contractual provisions, to establish and protect our intellectual property and other proprietary rights. We have applied for patent registrations in the U.S. and in other foreign countries, some of which have been issued. We cannot guarantee that our pending applications will be approved by the applicable governmental authorities. Moreover, our existing and future patents and trademarks may not be sufficiently broad to protect our proprietary rights or may be held invalid or unenforceable in court. A failure to obtain patents or trademark registrations or a successful challenge to our registrations in the U.S. or other foreign countries may limit our ability to protect the intellectual property rights that these applications and registrations intended to cover.

 

 26 
 

 

Policing unauthorized use of our technology is difficult and we cannot be certain that the steps we have taken will prevent the misappropriation, unauthorized use or other infringement of our intellectual property rights. Further, we may not be able to effectively protect our intellectual property rights from misappropriation or other infringement in foreign countries where we have not applied for patent protections, and where effective patent, trademark, trade secret and other intellectual property laws may be unavailable, or may not protect our proprietary rights as fully as Canadian or U.S. law. We may seek to secure comparable intellectual property protections in other countries. However, the level of protection afforded by patent and other laws in other countries may not be comparable to that afforded in Canada and the U.S.

 

We also attempt to protect our intellectual property, including our trade secrets and know-how, through the use of trade secret and other intellectual property laws, and contractual provisions. We enter into confidentiality and invention assignment agreements with our employees and independent consultants. We also use non-disclosure agreements with other third parties who may have access to our proprietary technologies and information. Such measures, however, provide only limited protection, and there can be no assurance that our confidentiality and non-disclosure agreements will not be breached, especially after our employees end their employment, and that our trade secrets will not otherwise become known by competitors or that we will have adequate remedies in the event of unauthorized use or disclosure of proprietary information. Unauthorized third parties may try to copy or reverse engineer our products or portions of our products, otherwise obtain and use our intellectual property, or may independently develop similar or equivalent trade secrets or know-how. If we fail to protect our intellectual property and other proprietary rights, or if such intellectual property and proprietary rights are infringed or misappropriated, our business, results of operations or financial condition could be materially harmed.

 

In the future, we may need to take legal actions to prevent third parties from infringing upon or misappropriating our intellectual property or from otherwise gaining access to our technology. Protecting and enforcing our intellectual property rights and determining their validity and scope could result in significant litigation costs and require significant time and attention from our technical and management personnel, which could significantly harm our business. We may not prevail in such proceedings, and an adverse outcome may adversely impact our competitive advantage or otherwise harm our financial condition and our business.   

 

We may be involved in intellectual property disputes in the future, which could divert management’s attention, cause us to incur significant costs and prevent us from selling or using the challenged technology.

 

Participants in the markets in which we sell our products have experienced frequent litigation regarding patent and other intellectual property rights. While we have a policy in place that is designed to reduce the risk of infringement of intellectual property rights of others, there can be no assurance that third parties will not assert infringement claims against us. We cannot be certain that our products would not be found infringing on the intellectual property rights of others. Regardless of their merit, responding to such claims can be time consuming, divert management’s attention and resources and may cause us to incur significant expenses. Intellectual property claims against us could result in a requirement to license technology from others, discontinue manufacturing or selling the infringing products, or pay substantial monetary damages, each of could result in a substantial reduction in our revenue and could result in losses over an extended period of time. 

 

 27 
 

 

If we fail to obtain the right to use the intellectual property rights of others that are necessary to operate our business, and to protect their intellectual property, our business and results of operations will be adversely affected.

 

From time to time we may choose to or be required to license technology or intellectual property from third parties in connection with the development of our products. We cannot assure you that third party licenses will be available to us on commercially reasonable terms, if at all. Generally, a license, if granted, would include payments of up-front fees, ongoing royalties or both. These payments or other terms could have a significant adverse impact on our results of operations. Our inability to obtain a necessary third party license required for our product offerings or to develop new products and product enhancements could require us to substitute technology of lower quality or performance standards, or of greater cost, either of which could adversely affect our business. If we are not able to obtain licenses from third parties, if necessary, then we may also be subject to litigation to defend against infringement claims from these third parties. Our competitors may be able to obtain licenses or cross-license their technology on better terms than we can, which could put us at a competitive disadvantage.

 

If we fail to maintain effective internal control over financial reporting in the future, the accuracy and timing of our financial reporting may be adversely affected.

 

Preparing our consolidated financial statements involves a number of complex manual and automated processes, which are dependent upon individual data input or review and require significant management judgment. One or more of these elements may result in errors that may not be detected and could result in a material misstatement of our consolidated financial statements. The Sarbanes-Oxley Act in the U.S. requires, among other things, that as a publicly traded company we disclose whether our internal control over financial reporting and disclosure controls and procedures are effective. As long as we qualify as an “emerging growth company” under the JOBS Act, which may be up to five years following the filing of our Form 20F Registration Statement, we will not have to provide an auditor’s attestation report on our internal controls. During the course of any evaluation, documentation or attestation, we or our independent registered public accounting firm may identify weaknesses and deficiencies that we may not otherwise identify in a timely manner or at all as a result of the deferred implementation of this additional level of review.

 

We have implemented internal controls that we believe provide reasonable assurance that we will be able to avoid accounting errors or material weaknesses in future periods. However, our internal controls cannot guarantee that no accounting errors exist or that all accounting errors, no matter how immaterial, will be detected because a control system, no matter how well designed and operated, can provide only reasonable, but not absolute assurance that the control system’s objectives will be met. If we are unable to implement and maintain effective internal control over financial reporting, our ability to accurately and timely report our financial results could be adversely impacted. This could result in late filings of our annual and quarterly reports under the Securities Exchange Act of 1934, or the Exchange Act, restatements of our consolidated financial statements, a decline in our stock price, suspension or delisting of our common stock by the TSX Venture Exchange, or other material adverse effects on our business, reputation, results of operations or financial condition. 

 

Our ability to use our net operating losses and certain other tax attributes may be limited.

 

As of March 31, 2017, we had accumulated net operating losses, or NOLs, of approximately $113 million. Varying jurisdictional tax codes have restrictions on the use of NOLs, if a corporation undergoes an “ownership change,” the corporation’s ability to use its pre-change NOLs, R&D credits and other pre-change tax attributes to offset its post-change income may be limited. An ownership change is generally defined as a greater than 50% change in equity ownership by value over a 3-year period. Based upon an analysis of our equity ownership, we do not believe that we have experienced such ownership changes and therefore our annual utilization of our NOLs is not limited. However, should we experience additional ownership changes, our NOL carry forwards may be limited.

 

 28 
 

 

We are subject to governmental export and import controls that could subject us to liability or impair our ability to compete in international markets.

 

We are subject to export and import control laws, trade regulations and other trade requirements that limit which raw materials and technology we can import or export and which products we sell and where and to whom we sell our products. Specifically, the Bureau of Industry and Security of the U.S. Department of Commerce is responsible for regulating the export of most commercial items that are so called dual-use goods that may have both commercial and military applications. A limited number of our products are exported by license under certain classifications. Export Control Classification requirements are dependent upon an item’s technical characteristics, the destination, the end-use, and the end-user, and other activities of the end-user. Should the regulations applicable to our products change, or the restrictions applicable to countries to which we ship our products change, then the export of our products to such countries could be restricted. As a result, our ability to export or sell our products to certain countries could be restricted, which could adversely affect our business, financial condition and results of operations. Changes in our products or any change in export or import regulations or related legislation, shift in approach to the enforcement or scope of existing regulations, or change in the countries, persons or technologies targeted by such regulations, could result in delayed or decreased sales of our products to existing or potential customers. In such event, our business and results of operations could be adversely affected.

 

Our manufacturing operations are subject to environmental regulation that could limit our growth or impose substantial costs, adversely affecting our financial condition and results of operations.

 

Our properties, operations and products are subject to the environmental laws and regulations of the jurisdictions in which we operate and sell products. These laws and regulations govern, among other things, air emissions, wastewater discharges, the management and disposal of hazardous materials, the contamination of soil and groundwater, employee health and safety and the content, performance, packaging and disposal of products. Our failure to comply with current and future environmental laws and regulations, or the identification of contamination for which we are liable, could subject us to substantial costs, including fines, clean-up costs, third-party property damages or personal injury claims, and make significant investments to upgrade our facilities or curtail our operations. Identification of presently unidentified environmental conditions, more vigorous enforcement by a governmental authority, enactment of more stringent legal requirements or other unanticipated events could give rise to adverse publicity, restrict our operations, affect the design or marketability of our products or otherwise cause us to incur material environmental costs, adversely affecting our financial condition and results of operations.  

 

We are exposed to risks and increased expenses and business risk as a result of Restriction on Hazardous Substances, or RoHS directives.

 

Following the lead of the European Union, or EU, various governmental agencies have either already put into place or are planning to introduce regulations that regulate the permissible levels of hazardous substances in products sold in various regions of the world. For example, the RoHS directive for EU took effect on July 1, 2006. The labeling provisions of similar legislation in China went into effect on March 1, 2007. Consequently, many suppliers of products sold into the EU have required their suppliers to be compliant with the new directive. We anticipate that our customers may adopt this approach and will require our full compliance, which will require a significant amount of resources and effort in planning and executing our RoHS program, it is possible that some of our products might be incompatible with such regulations. In such events, we could experience the following consequences: loss of revenue, damages reputation, diversion of resources, monetary penalties, and legal action.  

 

Failure to comply with the U.S. Foreign Corrupt Practices Act could subject us to penalties and other adverse consequences.

 

We are subject to the U.S. Foreign Corrupt Practices Act, which generally prohibits companies operating in the U.S. from engaging in bribery or other prohibited payments to foreign officials for the purpose of obtaining or retaining business. In addition, we are required to maintain records that accurately and fairly represent our transactions and have an adequate system of internal accounting controls. Foreign companies, including some that may compete with us, may not be subject to these prohibitions, and therefore may have a competitive advantage over us. If we are not successful in implementing and maintaining adequate preventative measures, we may be responsible for acts of our employees or other agents engaging in such conduct. We could suffer severe penalties and other consequences that may have a material adverse effect on our financial condition and results of operations. 

 

 29 
 

 

Natural disasters or other catastrophic events could harm our operations.

 

Our operations in the U.S., Canada and Singapore could be subject to significant risk of natural disasters, including earthquakes, hurricanes, typhoons, flooding and tornadoes, as well as other catastrophic events, such as epidemics, terrorist attacks or wars. For example, our wafer fabrication facility in Singapore is in an area that is susceptible to hurricanes. Any disruption in our manufacturing facilities arising from these and other natural disasters or other catastrophic events could cause significant delays in the production or shipment of our products until we are able to arrange for third parties to manufacture our products. We may not be able to obtain alternate capacity on favorable terms or at all. Our property insurance coverage with respect to natural disaster is limited and is subject to deductible and coverage limits. Such coverage may not be adequate or continue to be available at commercially reasonable rates and terms. The occurrence of any of these circumstances may adversely affect our financial condition and results of operation. 

 

The Company may experience these factors in the future and these factors may have a material adverse effect on the Company’s business, operating results and financial condition.

 

Please refer to the Company's Annual Information Forms filed on SEDAR for a detailed discussion of Risks and Uncertainties most recently filed on April 17, 2017.

 

Additional Information

 

Additional information relating to the Company is available on SEDAR at www.sedar.com including the information contained in the Company's Annual Information Form filed on SEDAR on April 17, 2017.

 

 

 

 

 

 

 

 

 

 

 30 
 

 

 

 

 

 

POET TECHNOLOGIES INC.

  Suite 1107, 120 Eglinton Ave. E 780 Montague Expy #107
Toronto, Ontario M4P 1E2     San Jose, CA 95131 USA
Tel: 416-368-9411   -   Fax: 416-322-5075
http://www.poet-technologies.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

31

 

 

EX-99.3 4 exh_993.htm EXHIBIT 99.3

Exhibit 99.3

 

FORM 52-109F2

CERTIFICATION OF INTERIM FILINGS

FULL CERTIFICATE

 

I, Suresh Venkatesan, Chief Executive Officer of POET Technologies Inc., certify the following:

 

1.Review: I have reviewed the interim financial report and interim MD&A, (together, the “interim filings”) of POET Technologies Inc. (the “issuer”) for the period ended March 31, 2017.

 

2.No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the period covered by the interim filings.

 

3.Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, results of operations and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

 

4.Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.

 

5.Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings:

 

(a)designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that:

 

(i)material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

(ii)information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

(b)designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

5.1Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is the Internal Control – Integrated Framework (2013) (COSO Framework) as issued by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission.

 

5.2ICFR: Not applicable

 

5.3Limitation on scope of design: Not applicable

 

6.Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on January 1, 2017 and ended on March 31, 2017 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

Date: May 11, 2017

 

 

By: /s/ Suresh Venkatesan

Suresh Venkatesan

Chief Executive Officer

 

EX-99.4 5 exh_994.htm EXHIBIT 99.4

Exhibit 99.4

 

FORM 52-109F2

CERTIFICATION OF INTERIM FILINGS

FULL CERTIFICATE

 

I, Thomas Mika, Chief Financial Officer of POET Technologies Inc., certify the following:

 

1.Review: I have reviewed the interim financial report and interim MD&A, (together, the “interim filings”) of POET Technologies Inc. (the “issuer”) for the period ended March 31, 2017.

 

2.No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the period covered by the interim filings.

 

3.Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, results of operations and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

 

4.Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.

 

5.Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings:

 

(a)designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that:

 

(i)material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

(ii)information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

(b)designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

5.1Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is the Internal Control – Integrated Framework (2013) (COSO Framework) as issued by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission.

 

5.2ICFR: Not applicable

 

5.3Limitation on scope of design: Not applicable

 

6.Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on January 1, 2017 and ended on March 31, 2017 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

Date: May 11, 2017

 

 

 

By: /s/ Thomas Mika

Thomas Mika

Chief Financial Officer

 

GRAPHIC 6 logo.jpg GRAPHIC begin 644 logo.jpg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logo_sm.jpg GRAPHIC begin 644 logo_sm.jpg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end